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            INTORDUCTION 
 
நந்தீசர்  மூலரகத்  தியருஞ் சட்டை 
   நாதரராடு  பதஞ்சலி  வியாக்கிரம பாதர் 
சுந்தரானந்தர் மச்சமுனி புண்ணாக்கீசர் 
   சுருதிகண்ை  கமலமுனி ரகாங்கணரும் பபாகர் 
மந்திரஞ்பசர் பகாரக்கர் சண்டிபகசர் 
   வரராமர்  காலாங்கியார் கூனக்கண்ணர் 
தந்திரருஞ்பசர் கருவூரார் ரிஷிகள் பதவர் 
     தபபாதனர்கள்  பாதமா  தார மாபம1 
 
The siddha science is a traditional treatment system generated from Dravidian 
culture2. The concept of system is the holistic system of codified life style a health care 
perfected many thousands of years .The siddha that system has a healthy soul can only be 
developed through healthy body,so they developed methods and medication that are 
believed to strengthen their physical body and thereby their soul. The siddha were many 
year ago in the Tamilnadu.This system is also called Tamil Maruthuvam3. Siddha focused 
to “Ashtamasiddhi” the eight super natural power.Those who attained or achieved the 
above said powers are known as siddhar .There were eighteen important siddhars in olden 
days and they developed this system of medicine.Hence it is called siddha 
medicine.4Generally the basic concepts of the siddha medicine recognizes predominance 
of vaadham, piththam,and kabham  in childhood ,adulthood,and old age  respectively5. 
The treatment of siddha medicine is aiming to keep the three humors in equilibrium and 
maintenance of seven elements .The treatment should be commenced as early as possible 
after assessing  the  course and cause of the disease. 
 
The drug use in siddha medicines were based five elements and treatment of  five 
properties:taste(suvai),character(gunam),potency(veeryam),class(pirivu),action(magiami)
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According to the mode of application ,the siddha medicine could be categorized into two 
classes ;Internal medicine and external medicine6.Siddhar were classified the diseases  on 
the basis of affected dhosam ,affected kosam into 4448 diseases. Among that yugi was 
classified the kuttam  as 18. Venpulli is one among them.7 
In modern science venpulli is termed as Vitiligo is a condition in which the 
pigment will be lost from the particular areas of the skin causing whitish patches, often 
with no clear cause .A condition in which the skin turns white due to the loss of pigment 
melanin that gives the skin8. Siddha system clearly lays down the general principles of 
body constituents in the classic bootha system .They hold that the universe is a 
macrocosum made up of the five primordial elements  or boothas ,viz nilam(earth),neer 
(water),thee(fire),vali(wind),veli (space) and the human being is a microcosum made up 
of these five element.  When there is a change in equilibirium of this five elements in 
macro cosum it influence the equilibirium of five elements in micro cosum.This 
imbalance leads to the course of a disease.9 
In the present days the environment is highly disturbed .The air is polluted, water 
is contaminated and food is mostly adulterated. These changes cause several disease in 
human beings .one of the disease the human are suffering is venpulli in modern medicine 
is related to vitiligo or leucoderma. The intention of this study of the author is to educate 
help and treat the patient suffering from venpulli .There are many challenging medicine 
found in siddha literature which play a miracle for treating skin disease especially 
vitiligo.vitiligo isa chronic skin condition characterized by portions of the skin losing 
their pigment10.The global percentage of people affected with vitiligo is less than 1% 
with some populations averaging 2-3% and rarely as high as 16% .The disease shows no 
regard to the ethnic, racial, or socio economic background of the affected sufferers. The 
cosmetic impact of this disease is tremendous and its psychological impact devastating 
particularly in coloured races11.Among them the author is interested to prove the efficacy 
of trial drugs.In the treatment of skin disease the Siddha system having wonderful 
medicine. So the author selected venpulli as her dissertation topic for which I have 
chosen. 
Rasacheenee chooranam –Internal12 
Karkadagasingi pattru –External 13 
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AIM AND OBJECTIVES 
AIM: 
The aim of my study is to evaluate the efficacy and safety of the siddha drug 
RASACHEENEE CHOORANAM (internal) and KARKADAGASINGI PATTRU 
(EXTERNAL) both clinically and experimentally in the treatment of VENPULLI. 
 
OBJECTIVES: 
  To collect the authorial measures and literature reviews of  
VENPULLI  in ancient siddha and modern literatures. 
 Have occupationan idea of the incidence of the disease with regard to 
age, sex, precipitating, socio economic status, food, kaalam and factors 
etc. 
 To expose the efficacy of siddhar’s diagnostic principles. 
 To utilize the modern investigation methods to confirm the diagnosis 
and prognosis. 
 To have clinical trial on patients with VENPULLI with 
selected siddha medicine. RASACHEENEE 
CHOORANAM (INTERNAL)  and 
KARKADAGASINGI PATTRU (EXTERNAL) 
 To evaluate 
 Toxicological screening 
 Acute 
 Sub acute 
 Sub chronic 
 To find out the statistical analysis of clinical study 
 Biochemical analysis  
 Physico chemical analysis   
 Bio-Statistical analysis  
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SIDDHA ASPECT 
இயல்: 
பதால் தடிப்புண்ைாகி உைம்பு முழுதும் தவளம்பபால ரவளூப்பாகும். 
இதில் மயிர் ரவளுப்பானால் அசாத்தியமாகும்.உதடு,உள்ளங்டக.குதம், 
குய்யம்,ரநருப்புபட்ை புண் பபால் நிறமிருந்தால் அசாத்தியம்,பமனி 
ரவடிப்பாகி ரவளுத்து வஙீ்கும்14. 
Venpulli (in yugi’s classification it is under 18 types or kuttam as swetha kuttam) Swetha 
kuttam (swetha –white) 
WHEN TO SUSPECT /RECOGNISE (DIAGNOSTIC CRITERIA) 
Venpulli is a chronic skin disease characterized by various sizes of hypopigmentar 
patches in the skin.According to siddha literatures if the lesions may be present in 
palms,soles, anal region, genetalia are incurable. 
தடிப்பாகத்  தவளனிரம்  பபால்  ரவளூத்துச் 
  சர்வாங்கமும்  ரவளூத்தாற்றான்  றரீும்பும் 
மடிப்பாக  மயிர்ரவளூத்தா  லசாத்ய  மாகும் 
  வரிவுதடுவுள்  ளங்டகக்குதங்குய்யந் 
ரநடிப்பாக  ரநருப்புப்பட்ைது  பபாற்புண்ணாய் 
  நிறமிருந்தா  லசாத்தியரமன்பற  யுடரக்க்கலாகும 
ரவடிப்பாக  பமனிரயல்லாம்  ரவளூத்து  வஙீ்கில் 
    ரவண்சுபவத குட்ைரமன்பற விளம்ப லாபம.15 
 
Aetiology: 
According to siddha system, the predisposing causes for this disease have been described 
as hereditary factor, stress, and strain, malnutrition and veneral exposure and no other 
specific causes have been mentioned for venpulli.  
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According to Thirumoolar karukkidaivaithiya nool 
              வியாதியுண் மூவாறு விலங்கிய குட்ைங்பகள் 
   சுயாதிக் கிரந்தி சுழன் பமகத்தாலாரும் 
 பயாதி மண்னுளப் பலவண்டினா ரலட்டும் 
    நியாதி புழுனாலாய் நின்றதிக் குட்ைபம16 
Six types of kuttam i.e skin disease are caused by kirandhi and megham, eight types are 
caused by insects in the soil, and four types are caused by worms. 
ACCORDING TO YUGHI VAITHIYA CHINTHAMANI 800 
விளம்பபவ மிகுந்த உஷ்ணந்தன் னாலும் 
      மிகுந்த சீதளத்தாலு மழற்சி யாலும் 
விளம்பபவ மந்தத்தால் வாந்தி யாலும் 
      மகத்தான ரபண்பணாடு மருவலலாலும் 
கிளம்பபவ கிபலசங்கள் மிகுதலாலும் 
      ரகடியான வுறக்கங்கள டைத லாலும் 
தளம்பபவ மயிருகற்கள் தவிடு மண்கள் 
    சாதத்திற் பருகலால் மிகுக்குங் குஷ்ைம். 
Excessive heat and cold, vomiting due to indigestion, unbridled sexual indulgence,and 
excessive sleep in day time, frequent intake of food mixed with stone and hair. 
குட்ைந்தான்  பதிரனட்டு  வரபவ  ரதன்னிற் 
குருனிந்டத சிவனிந்டத   மடரபயார்  நிந்டத 
திட்ைந்தான்  பதவடதடயத்  தூஷடனக்கு  பராதம் 
ரசப்பலாற்  றிருைலாற்  பரதா  ரத்டத 
அட்ைந்தா னாடசயால  டைக்க  லத்டத 
அபகரித்த  லகதிபர  பதசி  தன்டன 
வட்ைந்தான்  டவதலார்  கற்பழித்தல் 
வந்திடுபம  பதிரனட்டு  குட்ைந்தான். 
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Use of indescent and disrespectful words against god and highly religious and noble 
people, neglecting phans and beggars, intention to spoil others, raping, greed, cursing the 
elders   and so on have also been given as predisposing causes by yughi text.These habits 
are supposed to be the factors which lower the immunity of the body ( iyarkai vanmai) 
and make it vulnerable to the disease.17 
 
ACCORDING TO AGASTHIYAR KANMA KAANDAM: 
 
பசர்ந்பத  குட்ைரமாடு குடறபநாய்கள் வந்த 
    பசதி பகள்  மலராத வரும்பு  ரகாய்தல் 
தாரிந் சீவரசந்து வடதகள் ரசய்தல் 
    தாய்தந்டத மனது ரநாந்து பராந் தாபன 
தாரனன்ற  ரதய்வரு  தடனயழித்தல் 
  சார்வான ரபரிபயார்கள் தடமப் பழித்தல் 
காரனன்ற  நந்தவனம்  பூஞ்ரசடிகள்  ரவட்ைல் 
    கருமமைா சரீரத்திற் காசுபபாபல 
 
ஊரனன்ற  வுைம்ரபல்லாம் ரபாட்டு ரபாட்ைா  
     யுைன்  ரவளூத்து  குடறபநாயுதிரஞ் சிந்தும் 
வாரனன்ற  கருமங்கள் தீர்ப்பதற்கு 
         வடகரயான்று  ரசால்பவன்பகள். 
 
மலராத அரும்புரகாய்தல் சீவரசந்துகடள வடதகள்ரசய்தல், ரபற்பறார் மனடத 
பநாகும்படி ரசய்தல் ரபரிபயார்கள் தம்டமபழித்தல்,நந்தவனம் பூச்ரசடிகள் 
ரவட்டுதல் ஆகிய இக்காரணங்களால் குட்ைபநாய் வரும் என்று அகத்தியர் கன்ம 
காண்ைத்தில் கூறப்பட்டுள்ளது.18 
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CLASSIFICATION: 
ACCORDING TO YUGI VAITHIYA CHINTHAMANI: 
“முத்தாகும்  குட்ட்ந்தான்  பதிரனட்டுக்கும் 
    முனியான  யூகினான்  ரசால்லக்  பகளாய் 
புத்தாகும்  புண்ைரீக  குஷ்ைத்பதாடு 
   ரபருகின்ற  விற்பபாைகக்  குட்ைமாகும் 
பத்தாகும்  பாமா  குஷ்ை  ஏகசர்ம  குஷ்ைம் 
    பரிவான  கர்னகுஷ்ைம்  சர்மகுஷ்ைம் 
கித்தாகுங்  கிருஷ்ண  குட்ைம்  அவுதும்பர  குட்ைம் 
   பகடியான  மண்ைல  குஷ்ைமாகு  ரமன்பன 
குட்ைமா  மபரிச  குஷ்ை  பமாடு 
   மருவலாங்  கிடீப  குஷ்ைந்  சர்மதல  குஷ்ைந் 
திட்ைமாற்  தத்துரு  குஷ்ை  பமாடு 
   தக்கான  சித்துமா  குஷ்ைஞ்  சதாரு  குஷ்ைந் 
துட்ைமாஞ்  சுபவத  குஷ்ைதன்  பனாரைாக்கச் 
   சுயம்பான  பதிரனட்டுக்  குட்ைமாச்பச. 
             1.Pundareeka kuttam  
2. Virpodaka kuttam 
3. Baama kuttam 
4. Gaja saruma kuttam 
5. Karna kuttam 
6. Siguram kuttam 
7. Krishna kuttam 
8. Avudhubaram 
9. Mandala kuttam 
10. Abarisa kuttam 
11. Visarchika kuttam 
12 
 
12. Vibaathika kuttam 
13.Kideeba kuttam 
14. Sarmathala kuttam 
15. Thethru kuttam 
16. Sithuma kuttam 
17. Sathaaru kuttam 
18. Swetha kuttam19 
ACCORDING TO SIDDHAR ARUVAI MARUTHUVAM 
Venpadai has been classified into 3 types on the basis of mukkutram, they are, 
1. Vaatha venpadai  
2. Piththa venpadai 
3. Kaba venpadai20 
ACCORDING TO SIDDHA SIRAPPU MARUTHUVAM 
Venpulli has been classified into 4 types: 
1. Vaatha venpadai  
2. Piththa venpadai 
3. Kabha venpadai 
4. Mega venpadai21 
ACCORDING TO ATHMA RAKSHAMIRTHA VAIDHYA 
SARASANKIRAHAM 
Venpadai is classified into 4 types 
1. Venkuttam 
2. Senkuttam 
3. Karunkuttam 
4. Peru viyathi22 
CLINICAL FEATURES OF KUTTA ROGAM 
1.ACCORDING TO THANVANTHIRI VAITHIYAM 
 
“மீக்ரகௌத் பதாறூரமலுபமார் முகம் ரவளூக்குமாகில் 
             பநாக்கியல் மரிக்குஞ் ரசான்ன ரவண்குட்ைமாபம”23. 
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2.ACCORDING TO VAITHIYA SAARASANGIRAHAM 
 
Sole,Hands,lips,scalp,fingers and wrist joint-all those organs are found with white 
coloured patches which are circumscribed along with thickened border and gradually 
spread which is known as “venpadai”.Blood, Muscles, and adipose tissue are affected by 
disease. 
Discolouration of hairs ,absence of normal skin texture comparing the adjoining 
normal skin area and appearance of burns is not curable24. 
 
3. ACCORDING TO PARARAASA SEKARAM 
            1.Watery discharge 
2. Grey colour  
3. Foul smelling25 
4. ACCORDING TO ANUBHAVA VAITHIYA DEVA RAGASIYAM 
      இந்பநாடய குஷ்ைரமன கூறனீும் இது குஷ்ை வடககளின்று 
பவறுபட்ைது என்படதயும் குஷ்ைத்டதப்பபால் அவ்வளவு ரகாடுடமயான 
வியாதி அல்லரவன்றும் உணரபவண்டும்.இந்பநாயில் திட்டுதிட்ைாக ரவண்டம 
நிறமான படைகள் உண்ைாகி பிறகு பதகம் முழுவதும் பரவி உைடல 
விகாரப்படுத்ததுதல் முதலிய குணங்கடள உடையது. 
 
THREE TYPES 
1.Vatha venpadai 
2. Piththa venpadai 
3. Kaba venpadai 
 
CLINICAL FEATURES 
 
1.The skin appears glittering and rough 
2. There is an excessive perspiration  
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3. Discolouration 
4. Heat and itching of the skin 
5. Numbness in some parts of the body26 
 
5. ACCORDING TO SIRAPPU MARUTHUVAM 
1. Vaatha venpadai 
2. Piththa venpadai  
3. Kaba venpadai 
4. Mega venpadai 
 
1. VAATHA VENPADAI 
It is characterized by the depigmented patches, which are dry, rough,reddish with 
somewhat pale black in colour. 
 
2.PITHTHA VENPADAI 
It is characterized by the depigmented patches red in colour like lotus flower ,spreading 
with burning sensation and loss of hairs on that area 
 
3.KABA VENPADAI  
Itis characterized by the depigmented patches white in colour like leucus flower spreads 
with rashes and itching  
 
4.MEGA VENPADAI  
It is due to the veneral disease and it occurs after 4 or 6 months after the onset as disease, 
syphilis within four or six months of the attack .this venpadai develops initially along the 
nape and the adjoining spaces .Also gradually it affects the shoulder joints, back of trunk. 
Clinical features of this type are clearly defined by the author of “siddha maruthuva 
sirappu “as follow as depigmented patches are small in number .pale in colour ,turmeric 
colour or dark colour margin marked with hyperpigmented signs .These lesion are 
circumscribed with 2mm to 3mm diameter or above .this correct picture of 
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hypopigmented and hyper pigmented skin seems to be more or less a multi eyed filter ( 
sieve –like ) 
Females are more prone to this mega venpadai, therefore anti –syphilitic theraphy is 
mandatory in the early period of the treatment . 
CHARACTER OF VENPULLI 
 Skin color will change to reddish black or reddish white or white colour with spreading 
nature .the imbalance of the three thathus produces certain lesions in skin known as 
kuttam. 
Absence of perspiration and thickening of skin may produce the colour changes in skin  
 
       தரீும் ,தரீாதவை 
சாத்தியம்-11 
 பூண்ைந்  நுரவிபனாடு  சதாரிகம்  புண்ைரீ கந்த 
   தாண்டு  விற்பபாைம்  பாமாவுைன்  டமதலம்  ரவங்குட்ைம் 
கூண்டிடு  காகறந்தி  சிறுடம  யசல  குட்ைம் 
   பவண்டிய  வியாதிபயாடும் பதிரனான்றூம் விரித்துக் காபன.     
அசாத்தியம் 
ரசால்லுகுட்ைம் எழுவடகபபர் ரசால்லிக் கபால சர்மீகம் 
  ரவல்லு முதும்பா பமகிடிபம் விசர்ச்சிமண்ைலக் கிரமும் 
மல்லல் தருமீசி யகுடவ யாகும் ரபயபரா பரழாகும 
  வல்லகியாதிக் குணமதடன வகுத்துப் பாரிலுறூடரப்பபன்”     
CURABLE-11 
1.Thethru kuttam 
2. Sadhaaru kuttam  
3. Pundareega kuttam  
4.Virpodaga kuttam  
5. Sarmathala kuttam  
6.Baama kuttam  
7. Kaha nandhi 
16 
 
8. Venkuttam 
9. Sithuma kuttam 
10. Alasa kuttam 
11. Vibaathiga kuttam 
INCURABLE -7 
1.Kabaala kuttam 
2. Sarumamega kuttam  
3. Kideeba kuttam  
4. Avudhumbara kuttam  
5. Visarchika kuttam 
6. Aguvai kuttam  
7. Mandala kuttam27 
IN YUGI CHINTHAMANI-800 
குட்ைந்தான்  பதிரனட்டில்  சாத்தியந்தான் 
   கூறக்பகள்  விற்பபாைக பாமா குட்ைம் 
திட்ைைந்தான்  ரகசசர்ம  குட்ைரமாடு 
   கிருட்டிண  குட்ைமவுதும்பர  குட்ைந்தானும் 
திட்ைமாந்  பததிதிருக் குட்ைரமாடு 
    ரசய்சித்துமா குட்ைங்  கிடிப குட்ைம் 
தட்ைந்தான்  மிகுந்த சதாரு  குட்ைம் 
    சமகிருட்ண  குட்ைம்  சாத்தியமா  ரமன்பன”        
CURABLE -10 
1.Virpodaga kuttam 
2. Baama kuttam 
3. Gaja saruma kuttam 
4. Krishna kuttam  
5. Avuthumbara  kuttam 
6. Thethuru kuttam 
7. Sithuma kuttam 
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8. Kideepa kuttam 
9. Sathaaru kuttam 
10. Sarmathala kuttam 
INCURABLE -8 
1. Pundareeka kuttam 
2. Karna kuttam 
3. Sikura kuttam 
4. Mandala kuttam 
5. Abarisa kuttam 
6. Visarchika kuttam 
7. Swetha kuttam 
8. Vivadhika kuttam .28 
MUKKUTRA VAERUPADUGAL (PATHOGENESIS): 
 Disease occurs due to the derangement in 
 Uyir thathukkal 
 Udal thathukkal 
 Kalamarupadu (seasonal changes) 
 Thinai (living lands) and 
 Udal vanmai. 
 Mukkutra iyal: 
 The function of the three uyir thathus: 
a) Vali – Kattru + Veli 
b) Azhal – Thee  
c) Iyyam – Neer + Mann 
The alteration of three thathu in their reaction to extrinsic or intrinsic factors results in 
disharmony. This altered harmony and balance variation of the three results in disease. 
Their natural ratio (1:1/2:1/4) to each other is discerned by the physician at the wrist and 
each nadi is individually assessed for its strength, speed and regularity. 
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VATHAM 
 The term vatham denotes vayu, dryness, pain and flatulence. Based on functions 
and locations it is classified into ten types. They are tabulated below. 
S.No Vatham General Features Changes in  
venpulli 
1 Piranan 
(Uyirkkaal) 
Responsible for respiration and it is 
necessary for proper digestion. 
Normal 
2 Abanan 
(Keel nokkukkaal) 
Responsible for all the downward forces 
such as voiding of urine, stools, semen, 
menstrual flow. 
Normal 
3 Viyanan 
(Paravukaal) 
Dwells in the skin and is concerned with 
the sense of touch, extension and flexion of 
the parts of the body and distribution of the 
nutrients to various parts of the body. 
Affected 
(skin colour 
changed into 
white ). 
4 Uthanan  
(Melnokkukaal) 
Responsible for all kinds of upward motion 
such as nausea, vomiting etc., 
Normal 
 
5 Samanan 
(Nadukkaal) 
Considered essential for proper digestion, 
assimilation and carries the digested 
nutrients to each and every organ. 
Normal 
6 Nagan Helps in opening and closing of eyelids. Normal 
7 Koorman Responsible for vision, lacrimation and 
yawning. 
Normal 
8 Kirugaran Induces appetite, salivation, all secretions 
in the body including nasal secretion and 
sneezing. 
Normal 
9 Thevathaththan Induces and stimulates a person to become 
alert, get anger, to quarrel, to sleep etc., 
Normal 
10 Dhananjeyan Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of death, 
forming a way through the skull29. 
Normal 
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PITHAM 
 It is the thermal life force of the body. It is sub divided into five types. They are 
 
S.No 
 
Pitham 
 
General Features 
 
Changes in 
venpulli 
1 Anarpitham Peps up the appetite and aids in digestion. Normal 
2 Ranjagapitham Responsible for the colour and contents of 
blood. 
Affected 
 
3 Saathagapitham Controls the whole body and is held 
responsible for fulfilling a purpose. 
Normal 
 
4 Pirasagapitham Dwells in the skin and concerned with the 
shine, glow, texture and its complexion. 
Affected 
(skin color 
Changed 
into white) 
 chna 
 
 
5 Alosagapitham Responsible for the perception of vision30. Normal 
KABHAM 
 It is responsible for the stream line functions of the body and maintains body’s 
defence mechanism intact. It is again classified into 5 types. 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Kabham 
 
General Features 
Changes 
in venpulli 
1 Avalambagam Lies in the respiratory organs, exercises 
authority over other kabhas and control 
the heart and circulatory system. 
Normal 
2 Kilethagam Found in stomach as it seat, moistens the 
food, softens and helps to be digested. 
Normal 
3 Pothagam Responsible for the perception of taste Normal 
4 Tharpagam Presents in the head and is responsible for 
the coolness of the eyes, sometimes may 
be referred to as cerebrospinal fluid. 
Normal 
5 Santhigam Necessary for the lubrication and the free 
movements of joints31. 
Normal 
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PARUVAKALAM 
 
S.No Perum pozhuthugal Mukkutra marupaadugal 
1 Kaar kaalam 
(Aavani & Purattasi) 
Mid August to Mid October 
VATHAM - Vaetrunilai valarchi 
PITHAM – Thannilai valarchi   
2 Koothir kaalam 
(Iypasi & Karthigai) 
Mid October to Mid December  
VATHAM – Thannilai adaidhal 
PITHAM - Vaetrunilai valarchi 
3 Munpani kaalam 
(Margazhi & Thai) 
Mid December to Mid February  
PITHAM – Thannilai adaidhal 
4 Pinpani kaalam 
(Masi & Panguni) 
Mid February to Mid June  
KABHAM – Thannilai valarchi 
5 Elavenir kaalam 
(Chithirai & Vaikaasi) 
Mid April to Mid June  
KABHAM – Vaetrunilai valarchi 
6 Mudhuvenir kaalam 
(Aani & Aadi) 
Mid June to Mid August  
VATHAM – Thannilai valarchi 
KABHAM – Thannilai adaidhal32 
 
 
THINAI (LAND) 
 Siddhars classified the lands into five types. They are  
1. Kurunji – Mountain range 
2. Mullai – Pastoral area of the forest 
3. Marudham – The fertile river bed 
4. Neidhal – The coastal region 
5. Paalai – Arid desert 
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 Kabha diseases will occur in Kurinji land. Pitha diseases occur in Mullai land. 
Vadha diseases occur in Neidhal land. Staying in Paalai land is not good to health. 
Marudham land is the fertile area where no disease occurs. So, Marudham land is 
the best one to stay in. 
 The winter season gives good health to the man, early summer and later rainy 
gives moderate health. Whereas early rainy and later summer are more prone to 
diseases, that’s why siddhars called it as Aanaga kaalam.33 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND 
THINAIGAL: 
 
 
 
Mukkutram 
Paruvakaalam (Seasons)  
 
Thinai 
Thannilai 
valarchi 
(Accumulation) 
Vaetrunilai 
valarchi 
(Aggravation) 
Thannilai 
adaidhal 
(Alleviation) 
VATHAM Mudhuvenil 
kaalam 
Kaar kaalam Koothir kaalam Vatha disease is 
more prevalent in 
Neidhal land  
PITHAM Kaar kaalam Koothir kaalam Munpani kaalam Pitha disease is 
more prevalent in 
Mullai land 
KABHAM Pinpani kaalam Elavenil kaalam Mudhuvenil 
kaalam34 
Kabha disease is 
more prevalent in 
Kurunji land35 
 
UDAL VANMAI (IMMUNITY) 
 Siddhars classify udal vanmai into three types. They are 
1. Iyarkai vanmai 
2. Kala vanmai 
3. Seyarkai vanmai 
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UDAL KATTUGAL 
 
S.No Udal kattugal General Features Changes in 
venpulli 
1 Saaram 
 (Digestive essence) 
Responsible for the growth and 
development. It keeps the individual 
in good temperament and it enriches 
the body. 
 
Normal 
2 Senneer (Blood) Responsible for the color of the 
blood and for the intellect, 
nourishment, strength of the body. 
 Affected 
3 Oon (Muscle) Gives lookable contour to the body 
as needed for the physical activity. 
It feed the fat next day and gives a 
sort of plumpness to the body. 
Normal 
4 Kozhuppu (Fat) Lubricates the organs to facilitate 
frictionless functions. 
Normal 
5 Enbu (Bones) Supports and protects the vital 
organs, gives the definite structure 
of the body and responsible for the 
posture and movements of the body. 
Normal 
6 Moolai (Bone marrow) Nourishes the bone marrow and 
brain which is the centre that 
controls other system of body. 
Normal 
7 Sukkilam/Suronitham 
(Sperm/Ova) 
Responsible for reproduction36. Normal 
 
 
 
PINIYARI MURAIMAI (DIAGNOSIS) 
Four steps are followed in diagnosing the disease. They are 
1. Poriyaal aridhal 
2. Pulanal therdhal 
3. Vinaadhal 
4. Envagai thervugal 
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PORIYAAL ARIDHAL: 
 In this, the physician should carefully observe the changes that occur in the five 
sensory organs (porigal) of the patient. 
PULANAL THERDHAL: 
 The physician carefully applies his five senses of perception, smell, taste, vision, 
touch and sound to understand the condition of the patient. 
 
VINAADHAL: 
 The physician should interrogate about the patients name, age, occupation, socio- 
economic status, food habits, history of past illness, history of present illness, family 
history, marital status, menstrual history and frequency of pain37. 
 
ENVAGAI THERVUGAL: 
நாடிப்பரிசம் நாநிறம் ரமாழிவிழி
மலம் மூத்திரமிடவ மருத்துவராயுதம்
           Nowadays advanced diagnostic tools have been developed by modern bio medical 
scientists. But siddhars have given eight diagnostic methodological tools. They are called 
as Envagai thervu. 
 
 
Eight fold system of clinical assessments: 
 Siddhars have given eight diagnostic methodological tools. They are 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
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7. Malam 
8. Moothiram38 
 
GENERAL FINDINGS: 
NAADI: 
 Naadi is responsible for the existence of life, can be felt one inch below the wrist 
on the radial side by means of palpation with tips of index, middle and ring finger, 
corresponding to vatham, pitham, kabham. 
 Three humours Vatham, Pitham, and Kabham are in the ratio 1:1/2:1/4 normally. 
Derangement in these ratio leads to various disease conditions. 
Naadi nadai in venpulli 
   Vathapitham or Pithakabam39 
SPARISAM: 
 By sparisam, the temperature of skin (thatpam- cold or veppam – heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal growth of 
organs and tenderness can be felt. 
 In venpulli – affected area may be or  may not loss of  sensation  
NAA: 
 Signs and symptoms in the tongue are noted here. Colour, salivary secretion, 
ulcers, coating, inflammation, taste changes, deviation and its nature are generally noted. 
 In venpulli – in anaemic conditioned tongue may be Pallor. 
 
NIRAM: 
 The colour of the skin is noted here. 
 In  venpulli – The natural colour becomes pale or diminished 
 
MOZHI: 
 Character of the speech is noted, mainly uraththa oli (high pitched), thazhndha oli 
(low pitched), or resembles the sound of any instrument. 
 In venpulli – No changes in voice. 
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VIZHI: 
 Character of the eye is noted. Colour, warm, burning sensation, irritation, visual 
perception are generally noted. 
 In venpulli-Not affects. 
 
MALAM: 
 The stools are examined for quantity, hardening (malakattu), loose motion 
(bedhi), colour and smell. 
 In venpulli –normal  
 
MOOTHIRAM 
a) NEERKURI (Urine examination) 
 Urine examination is good diagnostic method compare to naadi and other 
Envagai thervugal. Theraiyar mention it as. 
     “அருந்து மாறி ரதமும் அவிபராதமதாய் 
     அக்கல் அலர்தல் அகாலவூன் தவிர்தழற் 
     குற்றளவருந்தி உறங்கி டவகடற 
     ஆடிகலசத் தாவிபய காதுரபய் 
     ரதாருமுகூர்த்தக் கடலக்குட்படு நீரின் 
     நிறகுறி ரநய்குறி நிருமித்தல் கைபன.” 
 
The early morning urine sample is collected and sample should be examined 
within one and hours.
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SIRUNEERIN POTHU GUNAM: 
 
 வந்த நீர்கரி எடை மணம் நுடர எஞ்சரலன
டறந்தியலுளடவ யடறகுது முடறபய 40 
The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai 
(Froth), Natram (Smell), Enjal (Deposits). 
NIRAM (COLOUR) 
NIRA THOGAI 
 
  பதீம் ரசம்டமடபங் கருடம ரவண்டமரயன்
பறாடதயங் ரகாழுடமடய ரயாத்துகு நீபர 41 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White  
Urine may be any colour as mentioned above.41 
EADAI (SPECIFIC GRAVITY) 
 Urine, not thick is considerably healthy. This is mentioned as 
                        “மிகத் தடிப்பும் மிகத் பதறலும் இன்பறனில் 
 சுகத்டதத் தரும் ரமய்ச் சுபாவ நீர் நன்பற.”42 
 
NURAI (FROTH) 
 Urine may be frothy in nature, if it is reduced in vali, azhal and ayyam are said to 
be deranged. This is mentioned as 
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பந்தரமய்ப் படசயிளகபடும் பருவத்
தந்தர்ப் பூதமாய் அனில மூதிரத்தில்
சம்பந்தபடும் ததினுடரப் புனபல 43
 
NEIKURI 
 The early morning urine of the patient is analyzed by dropping a drop of gingely 
oil on the surface of the urine sample. The accumulation, formations, changes, and 
dispersal under the sunlight without any external disturbances of the urine sample can be 
noted. 
The urine kept on the kidney tray in sun light, on non wind condition, should be 
examined by dropping a drop of gingili oil gently with rod. If oil spread like snake, it 
indicates vali neer; a ring indicates azhal neer and float like a pearl indicates iyya neer 
and sinks in urine indicates mukkutram. 
  “அரரவன நீண்டினஃபத வாதம் 
 ஆழி பபாற் பரவின் அஃபத பித்தம் 
 முத்ரதாத்து நிற்கின் ரமாழிவரதன் கபபம.”44 
 
 Vatha neer – The oil spreads like snake 
 Pitha neer – The oil spreads like ring 
 Kabha neer – The oil spreads like pearl 
 If the oil spreads gradually, it indicates good prognosis 
 If the oil spreads fast or gets mixed completely with urine or sinks in urine, it 
suggests bad prognosis43 
 
MANAGEMENT OF VENPULLI 
REJUVENATION: 
KALPA MARUNTHU  
Pothu kalpam, Ponnangaani karpam (alternanthera sessilis)(Used as recipes along with 
milagu (piper nigvum),kariuppu(sodium chloride )). 
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SIRAPPU: 
KITTIKIZHANGU (acalypha fruticosa) used as daily dishes like curry, vatral,etc.., 
Lemon used as pickle or juices (TO BE CONTINUED FOR SIX MONTHS) 
 Ayapirungaraja karpam 
 Ayajambeera karpam45 
KALPA YOGAM  
 Sarvangaasana is most useful for this complained shirasana is also useful, whereas 
the other asanam have been included for general health and fitness. 
 Pranayamam 
THE COMMON BENEFITS OF YOGAM  
 SARVANGASANAM  
USES:  
           It prevents narai ,thirai,and moopu .(i.e) prevents ageing .By stimulating the 
thyroid gland it givesa strength to all the organs  of the body .it cures kutta noi 
 
UNAVU 
TO BE ADD  
Bitter tasted foods  
Greens  
Sirukeerai( amarantus tricolor) 
“kanpuhaichal………pongumpitham ……. Sirukeerai thanai kol.” 
Pannai keerai (celosia argentea)-pannai yilankeerai yathu ….. karappan sirangu pun 
maatrum….. 
Paruppu keerai (Postulaca oleraceaa)-“pillai parupilaiku pithamarmum…….” 
Keerai thandu (amaranthus gangeticus )-senkeerai thandathu than theeratha pithathai 
thengaamal oati vidum…. 
 
TO BE AVOID  
Sour ,spicy,salty foods 
Curds ,oils,alcohol,sugar,non-vegetarian diet  
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Ulundhu(vigna mungo) 
Mustard 
Brinjal 
OTHER ADVICES: 
OLEATION:Oil bath should be taken twice a week is advisable  
 Be add bitter tasted herbs like azadirachta indica, acacia catechu etc.., 
 Palasu uppu (salt of butea monospermea)-For external application 
 De oleaginous substance the powdered form of illupai pinnakku bassia longifolia  
 Eechaam paai a type of mattress prepared from the leaves of phoenix sylvestris 
 Food stuff that bring the vaatha ,piththa and kabha dhoshas to the normal 
physiology level have to  be consumed46 . 
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                                    MODERN ASPECT 
 
THE SKIN  
Dermatology is the study of skin disease .Disease of the skin, are acommon occurrence, 
account for a great deal of misery, suffering in capacity and economic loss .A very few 
skin disease are contagious. 
Hippocrates, Father of medicine described many skin disease and divided into two groups 
according to their exogenous or endogenous causes. He attributed the origin of disease to 
abnormal mixing of black and yellow bile, blood and phlegm. The theory of abnormally 
mixed humors played a major role in dermatology for long time. 
Dermatology is the branch of medicine dealing with skin .its roots reach back to 
antiquity. The obviously manifested skin disease have drawn the attention of men since 
time immemorial.47 
 
SKIN ANATOMY 
The human skin is the outer covering of the body and is continous with the mucous 
membranes in the region of the mouth, nose,urogenital organs and the anus .In the adult 
skin surfaces measures 1.5-2m while the thickness of the skin varies from fraction of a 
millimeter to4mm. The thickness of the epidermis varies from 0.06 -0.9 mm. The 
thickness of the subcutaneous fat varies considerably. Some areas are devoid of fat while 
in others (on the abdomen and gluteal regions ), it is several centimeters thick .The mass 
of the skin of an adult accounts for approximately 5% While together  with subcutaneous 
fat for about 10 to 17.7% of the total body mass. 
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The colour of the skin may change because the amount of the pigment in it varies due to 
external and internal factors. The skin surface is covered with hairs over a great area. The 
areas devoid of hairs are the lips, palms and soles, glans penis, inner surface of the 
prepuce and the inner surface of the labia majorum and minorum 
 
Vascular System of Skin:  
 
Vascular system of the skin is formed of several networks of blood vessels. Large arterial 
vessels stretch from the fascia through the subcutaneous fat and give off small branches 
to the fat lobules. On the boundary of the dermis and hypoderm, they divide into 
branches which stretch horizontally and anastomose with one another. A deep arterial 
plexus of skin forms, which gives rise to branches supplying the holes of the sweat 
glands, the hair follicles and the fat lobules. The epidermis is devoid of blood vessels. 
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The most powerful network of blood vessels is located in the skin of the face, palms, 
soles, lips, genitals and in the skin around the anus. 
 
Lymphatic System of Skin:  
 
The lymphatic system of the skin forms superficial and deep networks. The superficial 
lymphatic network arises on the papillary layer as blind rounded dilated capillaries 
between which there are numerous anastamoses. The second network of lymph vessels is 
in the lower part of the dermis and already has valves. There is a network of wide loops 
forming lymphatic plexus and deeper parts are continuous with lymph trunks  
 
SKIN HISTOLOGY 
 
The skin develops from two germinative zones .The ectoderm which is represented by the 
epidermis (the most superficial skin layer). And the mesoderm (the middle embroyal 
layer) represented by two layers namely the true skin, or dermis (the middle layer) and 
the subcutaneous fat or hypoderm the deepest skin layer. 
 The boundary between th e epidermis and dermis forms a wavy line because of the 
presence of skin papilla (special outgrowth on the surface of the true skin) the spaces 
between which are filled with epithelial processes. 
 
LAYERS OF THE SKIN: 
 Skin is composed of three layers. The epidermis, dermis and the subcutaneous. 
EPIDERMIS  
The epidermis is defined as a stratified squamous epithelium which is about 0.1mm thick, 
although the thickness is greater (0.8-0.4 mm) on the palm and sole. Its prime function is 
to act as a protective barrier. The main cell of the epidermis is the keratinocyte which 
produces the protein keratin. 
The four layers the epidermis represent the stage of maturation of keratin by 
keratinocytes. 
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1.Basal cell layer( Stratum basale )  
2.Prickle cell layer (Stratum spinosum) 
3.Granular cell layer (Stratum granulosum) 
4.Horny layer (Stratum corneum) 
 
DERMIS:  
The dermis is defined as a tough supportive connective tissue matrix, containing 
.specialised structures .found immediately below and intimately connected with the 
epidermis. Two layers are distinguished in it. The papillary or sub epithelial layers and 
the reticular layer. The papillary layer is that part of the dermis which is found besstween 
the epidermis and the superficial network of blood vessel. The reticular layer merges with 
the subcutaneous fat is not demarcated from it sharply. The dermis is supportive 
connective tissue, mainly collagen, elastin and glycosaminoglycans. 
 
 SUBCUTANEOUS LAYER : 
 The subcutis consists of loose connective tissue and fat ( upto 3 cm thick on the  
abdomen ). 
 
 BLOOD AND LYMPHATIC VESSELS : 
 The skin also has a rich and adaptive bloodsupply. Arteries in the subcuits 
branchupwards,forming a superficial plexus at the papillary/ reticular dermal boundary. 
Branches extend  to the dermal  papillae .each of which has a single  loop of capillary 
vessels , one arterial  and one venous , Veins drain from the venous side of the loop to 
form the mid ;dermal  and subcutaneous  venous  networks . In the reticular and papillary 
dermis there are arteriovenous anstomoses which are well innervated and concerned with 
thermoregulation. 
The lymphatic drainage of the skin is important, and abundant meshes of lymphatics 
originate in the papillae and assemble into larger vessels which ultimately drain into the 
regional lymphnodes. 
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 PIGMENTATION OF THE SKIN  
 The colour of the skin may be brown or even black according tothe amount of pigment 
present and it varies due to external and internal factors.Even in white races most parts of 
the skin contain brown pigment granules in the deepest layer of the germanative zone of 
the epidermis. In dark races they are more abundant and extend throughout the whole 
zone.The degree of racial pigmentation does not depend on the number of melanocytes 
present but on their metabolic activity and the size and shape of their melanin producing 
organelles the melanosomes.  
Brownness of the skin depends upon the transfer  of melanosomes from melanocytes into 
keratinocytes .Melanosomes are cytoplasmic particle formed in melanocyted and then 
distributed among the basal cells of the epidermis .Each melanocytes in the epidermis 
secrets melanosomes are site of melanin synthesis by the action of tyrosinase upon 
tyrosine48.  
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MELANIN 
Melanin – Derived from the greek word melas, meaningblack. 
Melanin is complex black – brown polymersynthesized from the amino acid 
dihydroxyphenyl alanine (L-DOPA). 
The forms of melanin exists  
 Ordinary melanin known as eumelanin and a melanin synthesized from 
cysteinyl DOPA with a more reddish hue, known as phaeomealnin. 
 The initial part of melanin synthesis is catalysed by acopper containing 
enzyme complex known as tyrosinase which also catalyse the transformatiom 
of L.DOPA totyrosine. 
  MELANIN FORMATION  
Melanin, where ever it is found .is formed in the local cells by the enzyme 
tyrosinase (or) melanas . The mother substance, uponwhich the enzyme acts is a 
tyrosine derivative (DOPA) belevied to be formed in the adrenals. Melanin 
synthesis from the oxidation of phenylalanine or tyrosine is as follows: 
 
1. Tyrosine → DOPA → DOPA → Quinone  
2. DOPA - Quinone → 2-Carboxy2, 3 – dihydro – 5, 6 – dihyroxyindole.  
→2-Carboxy – 2, 3 – dihydro – indole -5, 6 – Quinone →5, 6 Dihydroxyindole.  
3. 5.6 Dihydroxyindole → Indole - 5, 6 Quinone → Melanin  
Melanin formation in both human and amphibian skin is augmented bythe hormone 
known as intermedian or melanocyte – stimulating hormone (MSH) secreted by the pars 
intermedian of the pityuitary gland. Adrenocarticotrophic hormone (ACTH) secreted by 
anterior pituitary has melanocyte stimulating activity similar to MSH although to a much 
lower degree. In Addison’s  disease   ACTH  is secreted  in a large  amount and thereis 
brownish  black pigmentation of  the exposed parts of  the skin  eg, Hands,feet  and 
mucous membrane. 
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Melatonin extract from bovine pineal gland, causes concentrated of melanin near the 
nuclei of mealnocytes in frog and asa result of this the skin becames pale. Its role in the 
human is not known. MSH causes the serum copper to rise and this is accompanied byin 
the melanin formation. Diminished formation of melanin is seen in albinism and 
leucoderma. In melanotic sarcoma, melanin may be found in the urine. 
Distribution:  
It is widely distributed in the body but peculiarly enough it is limited only to those 
structures which have got an ectodermal origin, for Eg: skin, hair, choroid coat of retina 
and substantia nigra of the brain.  
Functions: 
Melanin in keratinocytes is black and absorbs all visible light, The function of melanin in 
the choroids is namely to covert the eye ball into a perfect dark chamber. Since nervous 
tissue is derived from ectoderm, the melanin in the substantia nigra may represent the 
vestigial remnants of the melanin in the substantia nigra may represent the vestigial 
remnants of the melanin froming properties. Melanin is the great UVR and infrared 
radiation. It is also a powerful electron acceptor and may have other protective functions 
which as yet have been poorly characterized. 
 
Abnormal Pigmentation: 
Normal pigmentation of the skin is influenced of the amount and depth of melanin, by the 
degree of vascularity, by the presence of carotene and by the thickness of the horny layer. 
The amount of melanin produced is influenced by genetic factors, the amount and wave 
lengths of UV light received the amount of melanocyte. Stimulating hormone (MSH) 
secreted, and the effected of melanocyte stimulating chemical such as furocoumarins 
(psoralens) Abnormal pigmentation of the skin is produced by a variety of causes.  
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Types of pigmentary disorder:  
      Excessive pigmentation is known as hyper pigmentation and decreased pigmentation 
is known as hypo pigmentation. Both may be localized or generalized. In addition, 
increased pigmentation may result from deposits of abnormal non melanin pigments in 
the skin, E.g: Haemosiderin from broken down haem pigment in extravasated blood.  
 
Homogentisic acid deposited in cartilage particular in the inherited metabolic defect 
known as alkaptonuria.  
Drugs and heavy metals toxicity. Silver, Gold, Mercury, Arsenic poisoning, Amiodarone 
and phenothiazines causes slate grey, dusky skin pigmentation in exposed sites.49 
 
Vitiligo:  
The name ‘Vitiligo’ is derived from the Latin work skin eruption, victim meaning a 
blemish (spoil the beauty of) happens to be a synonym for it. White skin is the literal 
meaning of leucoderma, derma being derived from the Greek words, leucas and dermis. 
Leucas means white and dermis means skin.  
Celeus was the first Roman physician of the 2nd century to coin the word vitiligo, 
because the disease resembles the white patches of a spotted calf (vitelus).  
.  
Prevalence:  
About 0.5 to 1 percent of the world’s populations, or as many as 65 million people, have 
vitiligo. In the United States, 1 to 2 million people has the disorder. Half the people who 
have vitiligo develop it before age 20; most develop in before their 40th birthday. The 
disorder affects both sexes and all races equally; however, it is more noticeable in people 
with dark skin.  
Epidemiology: 
Vitiligo is an acquired idiopathic depigmentary condition which, though worldwide 
indistribution, is most common in India, Egypt and other tropical countries. It is a source 
of great social embarrassment of dark-skinned people. It affects all age groups with no 
predilection to either sex.  
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Gross Anatomical Changes in Vitiligo: 
Vitiligo represents an acquired patchy loss of pigments of the skin. There are no gross 
changes seen except irregularly demarcated, Hypo pigmented patches of varying size, 
usually surrounded by hyper pigmented skin. These are seen distributed symmetrically or 
asymmetrically at various parts of the body.  
 
I. Definition:  
Vitiligo is an acquired often disfiguring, pigmentary anomaly of the skin manifested by 
depigmented white patches surrounded by a normal or a hyperpigmented border.As a 
result, white patches appear on the skin in different parts of the body. Similar patches 
also appear on both the mucous membranes (tissues that line the inside of the mouth and 
nose), and the retina (inner layer of the eyeball). The hair that grows on areas affected by 
vitiligo sometimes turns white.  
It is an extremely common depigmentary disorder of great medicosocial significance 
among the dark people, etiology is uncertain association with variable penetrance; a 
symptomatic puncture linear, oval, circular or irregular, discrete or confluent 
depigmented and or hypopigmented macules on otherwise normal skin is confined to 
mucocutaneous functions dermatomal unilateral or bilateral, symmetrical or 
asymmetrical generalized or universal over laying hair retain pigment or turn white, no 
autonomic or sensory disturbances, sun burn or chronic solar damage in longstanding 
cases, impredictable and capricious course, stationary, self-healing or progressive.  
It is quite clear that vitiligo is due to some derangement in the pigment metabolism 
resulting in appearance of white patches in the skin. It is hard to say whether the site of 
derangement is usually general or local, but the main affected part is the skin, which is 
the most exposed part of the body. It can be examined by naked eye and can furnish a lot 
of information about the personand the disease. In certain cases the changes are not clear. 
Hence the study of the skin structure and its physiology is essentials for proper 
assessment. 
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II. Etiology & Pathogenesis:  
 
may be inherited and about one fourth to one third of patients have family 
members affected with the disease. A multifactorial pattern of inheritance is 
revealed is most studies.  
pigment-producing cells of the skin, have been suggested by different workers.  
autoimmune hypothesis originated from the observation that vitiligo is 
associated with some autoimmune diseases. Both cellular and humoral factors 
responsible for autoimmune damage to melanocytes have been demonstrated.  
 
These autoimmune diseases include hyperthyroidism (an overactivethyroid gland), 
adrenocortical insufficiency (the adrenal gland does not produce enough of the hormone 
called corticosteroid), alopecia areata (patches of baldness), and pernicious anemia (a low 
level of red blood cells caused by the failure of the body to absorb vitamin B12), and it is 
also common in diabetes mellitus. Scientists do not know the reason for the association 
between vitiligo and these autoimmune diseases. However, most people with vitiligo 
have no other autoimmune disease.  
 autocytotoxic or self-destruct hypothesis suggests that some toxic 
molecules produced during the biosynthesis of melanin are responsible for 
melanocyte damage is susceptible individuals.  
 neural hypothesis postulates that neurochemicals liberated from nerve 
endings are toxic to melanocytes.  
Drugs and chemicals – like quinines, guano furacin, amylphenol, chlorthiazide, broad 
spectrum antibiotics and chloroquin.  
It is also regarded to develop through eczema scar of prick by injection needle, injury by 
burn or from other accidents, by friction of foot, wearing tight clothes. It has also been 
observed in persons who have suffered seriousillness due to typhoid, jaundice, liver 
diseases, diabetes, worms, constipation and diarrhea.  
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The non-pigmented patches whitish or reddish are round or oval in shape with smooth 
surface and slowly grow into large, irregularly outlined areas. It may be the result of skin 
diseases or it may be harmless conditions of unknown cause.  
 
Hereditary Factors  
Hereditary is one of the factors supposed to be related with venpulli Familial incidence 
has been reported in 7.5 to 21% in India and 33 to 40% in western countries.  
 
Emotional Factors  
It is every day knowledge and observation that emotional factors affect the skin as shown 
by the blushing of embracement, the pallor of fear and the pallor or redness of Change, 
depending on the subject and his emotional state. Experiments have demonstrated that 
emotional change can affect the following, which has direct relevance in the etiology of 
certain skin disorders.  
cularity of the skin  
 
 
 
 
There is due to the causative factor of this disease, venpadai from the following basic 
facts, it is generally considered to be a trophoneurosis. Psychological factors are known 
to be responsible for the precipitation and aggravation of the disease.  
 
Others  
 
Sometimes vitiligo can be caused by the action of monobenzyle either on hydroquinone 
presents in the slippers, gloves (or) other articles made of rubber or used as a 
depigmenting agent in the form of an irritant for pigmentary disorders. Recently vitiligo 
has also been observed to occur from plastic slippers as well as plastic ‘hindis’50 
 
.  
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III. Pathology:  
 
Chemically melanin pigment is a group of chromo proteins with coloured prosthetic 
groups, which is derived from the precursor tyrosine in the following way Tyrosine 
tyrinase Dihydroxy phenylanin (DOPA) Melanogenase Melanin (Dopa oxidase).  
Melanin +Protein = Melano protein 
 
 
The possible pathogenetic mechanism, a schematic picture of the causal and 
temporal sequence leading to the melanocyte functional impairment during vitiligo: 
     In the skin, the pigment is produced by the melanocytes of their precursor’s 
melanoblasts. The melanoblasts are supposed to be derived from the cells of neuro 
ectodermal origin during the embryonic life. After birth, these cells migrate to their 
definitive position. The melanocytes appear as clear cells within the basal cell layer of the 
epidermis and show dendritic processes after special staining. These processes come in 
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contact with similar process of other melanocytes and epithelial cells through which the 
melanin pigments are donated to the basal cells of epidermis. The dermis of normal skin 
also shows macrophages containing melanin pigments known as melanophores, which 
are incapable to produce the melanin pigments. 
 
Histopathalogic changes in Vitiligo  
Marked histological changes do not occur in cases of Vitiligo. All the layers of the 
epidermis and dermis appear normal except a few changes which can be seen after 
special stains.  
In the affected area the basal cells and the keratinizing cells of the other layers of 
epidermis do not contain melanin pigment granules in them. The contrast can be seen at a 
junction of the normal and vitiligenous areas of the skin, especially by silver staining or 
DOPA reaction. The pigment cells, the melanocytes are not seen in the affected area but 
they are present in the adjacent normal skin. At the border of the patches of vitiligo the 
melanocytes often appear large and posse’s long dendritic process filled with melanin 
granules. Electron microscopic studies confirm the absence of melanocytes in areas of 
long standing vitiligo.  
There are collections of mononuclear cells at dermo epidermal junctiojunction at the 
border between vitisliginous and normal skin. These cells are predominately small 
lymphocytes. In the long standing case where the skin has become thick and scaly, 
varying amount of the keratosis is seen. 
 
IV. Clinical Features:  
Vitiligo affects all races with an average frequency of 1 to 2 percent of the 
population. Both sexes are affected equally and the disease may develop at any 
age. The peak age of on set in most series was between 10 and 30 years. Stressful 
life events or physical trauma can often precipitate the onset of disease.  
 typical macule of vitiligo is easily recognized by well-circumscribed milky 
white spots of varying sizes without any other discernable surface change of the 
skin. The hairs on the patch may turn gray or white (Leucotrichia). There may be 
a single spot or numerous white macules distributed all over the body. With 
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passage of time, the macules may enlarge and coalesce to produce extensive 
pigment loss. The lesions are symptomless.  
 the depigmented areas are slightly pink at the start of the disorder.  
distributed over the peripheral parts of the limbs and the face.  
nd on sun-exposed areas of the body, 
including the hands, feet, arms, face, and lips. Other common areas for white 
patches to appear are the armpits and groin, and around the mouth, eyes, nostrils, 
navel, genitals, and rectal areas.  
 patches on the skin, people with vitiligo may have 
premature graying of the scalp hair, eyelashes, eyebrows, and beard. People with 
dark skin may notice a loss of colour inside their mouths.  
igmentation 
occurs over the front of the neck over the thyroid gland, or on the abdomen over 
the site of the pancreas or on the flanks over the sites of the adrenal glands.  
new lesions at sites of non-specific trauma such as abrasion, surgical scars, severe 
sunburn or inflammatory skin diseases like psoriasis or eczema.  
the sun.  
appears spontaneously after months or years but more 
usually the conditions spreads slowly and may eventually involve nearly whole of 
the skin.  
helps to confirm the diagnosis. Patches enlarge slowly and may affect the whole 
body.  
 
V.Types:  
According to the extent of involvement and pattern of distribution, vitiligo is 
clinically categorized into focal, segmental, generalized, acrofacial, and universal 
types.  
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Focal vitiligo is an isolated macule or a few macules in a localized non-
dermatomal distribution.  
Segmental vitiligo is characterized by macules in a unilateral dermatomal 
distribution. This type of disease usually pursues a stable course.  
Generalized vitiligo is the most common type showing macules in a 
generalized widespread distribution. There is often striking symmetry of affection 
and involvement of extensor surfaces. Face (particularly around the orifices), 
neck, bony prominences of hands, legs; axilla and mucosal surfaces are 
particularly affected.  
Acrofacial vitiligo affects distal end of fingers and facial orificies in 
circumferential pattern.  
Universal Vitiligo implies loss of pigment over the entire body surface area 
with with only isolated islands of normal pigmentation remaining.  
 
VI. Associated diseases:  
diseases like thyroid diseases, Addison’s disease, pernicious anemia and insulin-
dependent diabetes mellitus. Auto antibodies against other organs may be 
detected in the absence of clinical evidence of the diseases. Premature graying of 
hair and alopecia areata are important cutaneous associations in some patients.  
entally derived 
from the neural crest, the cutaneous melanocytes originate from the same 
embryonic structure. They ma share the susceptibility to damage in vitiligo; iris 
and retinal pigmentary anomalies in the absence of ophthalmologic complaints 
may be detected in a proportion of the patients. Iris may be found in a small 
number of patients.  
 
Psychosocial impact of vitiligo  
 
 vitiligo by itself is symptomatic and does not cause any physical 
discomfort or disability, it may be associated with devastating psychological and 
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social consequences. Since a person’s appearance is a major determinant of 
his/her personality traits, vitiligo, by causing cosmetic blemishes can have major 
impact on personality.  
lowered self-esteem may be detrimental to the patients, particularly when the 
spots are a visible area of the body.  
races such as Indians, in whom the contrast between the normally dark skin and 
the white lesions can be marked.  
 
Clinical Criteria for Classification of Vitiligo:  
Stages of Clinical Features  
Vitiligo  
 
Active (VI)  
(i) New lesions developing  
(ii) Lesions increasing in size  
(iii) Border ill-defined  
 
Quiescent (V2) 
(i) No new lesions developing  
(ii) Lesions stationary in size  
(iii) Border hyper pigmented and well- defined.  
 
Improving (V3) 
(i) Lesions decreasing in size  
(ii) No new lesions developing  
(iii) Border defined and signs of spontaneous regimentation  
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Zosteriform: 
Unilateral distribution of lesions, preferably along the course of nerves. Besides typing 
the stage of disease, it is useful to decide the variety (acral, Vulgaris, Zosteriform), 
Severity (Localized or extensive) and acuity (insidious or galloping) of vitiligo.  
 
VII. Diagnosis:  
The diagnosis of vitiligo is made based on a physical examination, medical history, and 
laboratory tests.  
 
Physical examination:  
White patches of skin on the body-particularly on sun-exposed areas, including  the 
hands, feet, arms, face, and lips.  
 
Medical History:  
Important factors in the diagnosis include a family history of vitiligo; a rash, sunburn, or 
other skin trauma at the site of vitiligo 2 to 3 months before depigmentation started; stress 
or physical illness; and premature (before age 35) graying of the hair and ask whether 
patient or anyone his family has had any autoimmune diseases, and whether patients are 
very sensitive to the sun.  
 
Laboratory tests:  
To help confirm the diagnosis, we make take a small sample (biopsy) of the affected skin 
to examine under a microscope. In vitiligo, the skin sample will usually show a complete 
absence of pigment-producing melanocytes. On the other hand, the presence of inflamed 
cells in the sample may suggest that another condition is responsible for the loss of 
pigmentation.  
It is usually apparent; in doubtful and early case, Wood’s lamp is of great help in 
diagnosis.  
These areas often fluorescence a golden yellow when examined under a Wood’s lamp. 
The hypomelanotic macules in leprosy are anesthetic.  
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Examination of the skin in long wave UVR helps distinguish whether there is total 
depigmentation (as in Vitiligo) or not. It may also detect areas of depigmentation not 
easily seen in ordinary daylight, as well as detecting a lemon-yellow fluorescence seen in 
some cases of pityriasis versicolour.  
 
VIII. Course and prognosis:  
The common generalized vitiligo usually pursues a course of slow progression with 
enlargement of existing macules and gradual appearance of fresh spots. Quite often, after 
an initial phase of progression, the lesions remain relatively stable for varying periods of 
time only to be followed by accelerated spread, sometimes there may be very rapid 
spread leading to extensive loss of pigmentation within a short span of time. In an 
individual case the course however is unpredictable.  
In comparison with the aforesaid, segmental vitiligo tends to have a very stable course. 
Following appearance of lesions in a dermatomal distribution, the lesions usually remain 
localized to the area of affection.  
Spontaneous regimentation may be observed in a proportion of patients particularly in 
lesions on sun-exposed areas. However, the extent of spontaneous healing is seldom 
cosmetically significant.  
It has improved considerably in recent years because of better understanding of 
etiological factors and advances made in therapy.  
Following conditions are said to be of poor prognosis.  
s1) Poor nutritional state or digestion, use of broad – spectrum antibiotics over long 
period. Emotional stress and nervous debility.  
2) Presence of vitiligo on resistant sites like the hands and the feet, front of wrists, the 
elbow, the waist, the eyelids and lips.  
3) Depigmented hair in vitiliginous areas.  
 
Other Causes of Hypo Pigmentation:  
Generalised depigmentation is found mostly in albinos. In this case, the characteristic 
dendritic melanocytes are present in the skin, but they are unable to produce melanin 
pigment due to defective tyrosinase activity. In albinism, the skin looks milky white, the 
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hairs are pale looking and the iris is transparent. The generalized pallor is also noticed in 
panhypopituitiarism, male eunuchoidism and phenyl ketouria.  
Localised depigmentation is often noticed in the skin of pattern leucoderma. The white 
patches on the skin may be quite extensive and the condition is inherited as an autosomal 
dominant character.  
Sometimes sharply defined focal depigmented areas are found on skin of persons 
suffering from vitiligo. In the affected areas, melanocytes are absent and there is no trace 
of  melanin. The condition is an acquired one and shows some familial tendency. 51 
 
 
Leucoderma:  
Leucoderma may be defined as a type of acquired skin depigmentation produced by some 
specific substances (or) dermatosis several types of Leucoderma may be seen  
1. Occupational Leucoderma may occur in those who work in rubber 
garments (or) wear gloves that contain antioxidant monobenzyl ether of 
hydroguinone many phenolic compounds can produces Leucoderma.  
2. Postinflammatory Leucoderma may result from many inflammatory 
dermatoses such are, Pityriasis rosea, psoriasis, herpes zoster, secondary 
syphilis, and morphea.  
 
Burns, scars post dermabrasion and intralesional steroid injections with depigmentation 
are other examples of Leucoderma  
Leucoderma is also commonly seen on the flanks of ladies wearing tight petticoat strings 
where the prolonged pressure is presumed to lead to depigmentation.52 
 
 
Piebaldism: 
In this condition there is a white forelock and white patches on the skin surface. In 
waardenburgs syndrome the condition associated with sensory deafness. 
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Pityriasis Versicolour  Superficial fungus infection leading to 
disturbance in pigment production, 
common multiple pale scaling patches on 
trunk  
 
Pityrisis alba  Mild patchy eczema of the face in 
children causing a disturbance in 
pigment production.  
 
Leprosy  One or several paler macules on trunk or 
limbs that are hypo aesthetic.  
 
White macules of affecting tuberous 
sclerosis  
Uncoming development of anomaly of 
CNS, connective tissue and skin; several 
“maple leaf” shaped hypopigmented 
macules.  
 
Postinflammatory hypopigmentation  After inflammatory skin disease (after 
eczema or trauma to the skin; irregular in 
shape and in depth of pallor).  
 
Naevous anaemicus  Rare developmental solitary white patch 
usually on trunk; thought to have 
vascular basis  
 
Chemical toxicity  May look very much like vitiligo; seen in 
workers in rubber industry exposed to 
parateriary benzyltoluence.  
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DIFFERENTIAL DIAGNOSIS OF THE IMPORTANT  
DEPIGMENTARY DISORDERS 
 
Distinguish 
features  
Albinism  Naevus  
Depigmentosus  
Vitiligo  Leprosy  Pityriasis  
Age  Congenital 
present at 
birth  
Congenital  
present at birth  
Acquired  Any age  Any age  
Distribution  Complete (or) 
Partial  
Unilateral  Any area  Any area  Trunk, Neck, 
and Face  
Course  Stationary  Does not increase 
in size or changing 
shape  
Progressive  Progressive  Progressive; 
worse in 
mansoon and 
summer  
Hyper  
pigmentary  
border  
Nil  Nil Present  Inflammatory  Nil  
Heredo family 
 
Hereditary  No  thereditary Rare  Nil  Nil  
Other features  Hair and eyes 
may be 
affected  
Nil  Hair may 
be affected  
Anesthesia 
thickened 
nerves, nasal, 
bleeding slit 
smear and 
biopsy  
Furfuraceous 
like dandruff, 
scaling in 
head macules 
and large 
patches 53 
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VITILIGO AREA SEVERITY INDEX (VASI): 
             Its name is an adoption from PASI score in psoriasis. The percentage of vitiligo 
involvement is calculated in terms of hand units. One hand unit is approximately 
equivalent to 1% of the total body surface area. The degree of pigmentation is estimated 
to the nearest of one of the following percentages: 100% - complete depigmentation, no 
pigment is depigmentation]present; 90% - specks of pigment present; 75% - depigmented 
area exceeds the pigmented area; 50% - pigmented and depigmented areas are equal; 
25% - pigmented area exceeds depigmented area; and 10% - only specks of 
depigmentation present [1,3]. The VASI for each body region is determined by the 
product of the area of vitiligo in hand units and the extent of depigmentation within each 
hand unit measured patch. Total  
body VASI = S All body sites [Hand Units] ´ [Residual depigmentation] [1]. 
The VASI for each body region is determined by the product of the area of vitiligo in 
hand units and the extent of depigmentation within each hand unit measured patch. 
Total body VASI = S All body sites [Hand Units] ´ [Residual  
 
VASI score ~−50 Very much worse 
VASI score -50 -25 Much worse 
VASI score -26 -10 Worse 
VASI score -10  0 Minimally worse 
VASI score 0 10 Minimally improved 
VASI score 10 25 Improved 
VASI score 25 50 Much improved 
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VASI score +50~ Very much improved 
    
CALCULATION: 
  
         The body is divided into four sections (head (H) (10% of a person's skin); arms (A) 
(20%); trunk (T) (30%); legs (L) (40%)). Each of these areas is scored by itself, and then 
the four scores are combined into the final PASI. For each section, the percent of area of 
skin involved, is estimated and then transformed into a grade from 0 to 6: 
 0% of involved area, grade: 0 
 < 10% of involved area, grade: 1 
 10–29% of involved area, grade: 2 
 30–49% of involved area, grade: 3 
 50–69% of involved area, grade: 4 
 70–89% of involved area, grade: 5 
 90–100% of involved area, grade: 6 
Within each area, the severity is estimated by three clinical 
signs: erythema (redness), induration (thickness) and desquamation (scaling). Severity 
parameters are measured on a scale of 0 to 4, from none to maximum. 
The sum of all three severity parameters is then calculated for each section of skin, 
multiplied by the area score for that area and multiplied by weight of respective section 
(0.1 for head, 0.2 for arms, 0.3 for body and 0.4 for legs). 
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TRIAL DRUG 
 
         இரசச்சனீசீ் சூரணம் 
கண்டிட்ட ரசச்சீனசீ் சூரணத்தைககளு 
  காணுரசஞ் சுத்ைிசசய்துபல முக்கால்ைான் 
விண்டிடகவ கெந்திச ாரு பலந்ைானப்பா 
  கேலான அரிதாரம் பலந்ைான்சரண்டு 
பண்டிட்ட நற்பரங்ெிபட்டை பலம்ணாலு 
  பாரடா கொடிவேலிகவரின்பட்தட 
துண்டிட்டு ஒன்றதரைான் பலகேகபாடு 
  சசால்லாசை எட்டிவிதைபலந்ைா ஒன்கற 
பலத்ைாகல நிறுத்து கல்லுரலிலிட்டு 
  பகருஞ் வசங்கொட்டை ஐந்து வறுத்துப்கபாடு 
சபலத்ைாகல இடித்துச் சூரணகே சசய்து 
  கபனிக  அந்ைிசந்ைி இளசவந்நீரில் 
நலத்கைாகலஒருசபாழுதுக்கதரக்கழஞ்சி 
  நல்கிடகவ பத்ைி த்தை நாட்டக்ககளூ 
ககாழிச ாடு துவதரயு மூர்க்குருவி ாகே 
 
ஆகாது புளயீுப்பு கசப்பு மூன்றும் 
  அப்பகனபைிதனந்து ைினம் கபாேட்டும் 
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ஏகாை பிண ீகலும் வதகத க்ககளூ 
  ஏழுமூலங் கருங்குட்ட ேண்டவாைம் 
கபாகாை சசங்குட்டம் கேண்குட்ைங்ெள் 
  புருடருட பிளதவைண்டுக் கிரந்ைிப்புண்கள் 
சாகாை அதர ாப்புச் சூதலச ல்லாந் 
  ைான்சகட்கட சனன்றுப் கபாந்ைான் கண்டீகர. 
                    அெத்தியர்ேல்லாதி 600 (பக்ெஎண்:119-120)54 
 
INGREDIENTS  
                  RASACHEENEE CHOORANAM 
         1. Suthitha Rasam -Hydragyrum - (Mercury Quick Silver) -3/4 Palam(28 gm ) 
         2. Suthitha Ganthagam - (Sulphur)-1palam (35 gm) 
         3. Suthitha Thalagam - Arsenic (Arsenic-orpiment/ Yellow Arsenic Trisulphide)- 
   2palam(70 gm) 
         4. Parangipattai - (Smilax China) -4palam (140 gm)     
         5. Kodiveli  Vearpattai-  (Plumbago Indica)-1 1/2palam(52.5gm)   
         6. Eattivithai - (Strychnos Nux Vomica) - 1palam (35 gm)   
         7. Searangkottai - (Semicarpus Anacardium) -5numbers 
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ACTIONS OF TRIAL DRUGS: 
 
 
S.No Drugs Botanical name Actions 
1 Parangippattai Smilax china.linn. Alternative 
Antisyphilitic 
Aprodisaic 
Depurative55 
2 Etti Strychnos nux –vomica .linn Antiseptic 
Tonic 
Diuretic 
Stimulant 
Carminative 
Purgative56 
3 Kodiveli 
vearpattai 
Plumbago indica Tonic 
Stomachic57 
4 Serangkottai Semecarpus anacardium.linn.f Alterative 
Caustic58 
5 Rasam Hydrargyrum(mercury of 
quicksilver) 
Diuretic 
Sialagogue 
Tonic 
Alterative 
Antibilious59 
 
6 Ganthagam sulphur Cholagogue 
Diaphoretic 
Alterative60 
7 Thalagam  Yellow arsenic trisulphide Expectorant 
Alterative  
Tonic 
Antidote61 
 
வசராங்கொட்டை கபாதுகுணம்: 
                         குட்ைம் க கராகங் சகால்லும் விடபாகந் 
துட்டந்ைரு கிருேி சூதலயும் கபாம் ேட்டலருங் 
கூந்ைன்ே ிகல கிரந்ைிக் குட்டம்கபாஞ் சசங்தக ில் 
ஏந்து கசங்சகாட்தட ைதனக .62 
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      ெந்தெம் கபாதுகுணம்: 
சநல்லிக்காய்க் கந்ைிக்குநீள் பதிகனண்குட்ை மந்தம் 
வல்தல கவிதச குன்ேவாயு கண்கணாய் – சபால்லா 
விடக்கடிவன் கேககநாய் வறீுசுரம்கபைி 
ைிடக்கிரசுண ீகபம் கபாந்கைர்.63 
இரசம் கபாதுகுணம்: 
 
விழிகநாய் கிரந்ைி குன்ேம் சேய்ச்சூதல புண்குட் 
டழிகாலில் விந்துவினால் அத்தை – வழி ாய் 
புரியு விைி ாது புரி ிகனா ச ல்லாம் 
இரியு விைி ாதுேில்.64 
STANDARD OPERATIVE PROCEDURE 
INTERNAL MEDICINE                                                                                        
    Purified herbo mineral ingredients (except semecarpus) are finely powdered into the 
stone morter then properly purified semecarpus add to the above powder, mixed together  
well and bottled up.         
EXTERNAL MEDICINE           
Karkadagasingi powder is mixed with kaadi and apply to the affected area.                                                    
DOSAGE:10 mg twice aday 
ADJUVANT: Palm jaggery 
DURATION: 48  Days, 
59 
 
                           INGREDIENTS OF TRIAL DRUG 
 
சுத்திக்கு முன்-இரசம்               சுத்திக்கு பின்-இரசம் 
                   
சுத்திக்கு முன்-கந்தகம்            சுத்திக்கு பின்-கந்தகம் 
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சுத்திக்கு முன்-தாளகம்             சுத்திக்கு பின்-தாளகம் 
              
 
எட்டி                                 பறங்கிப்பட்வை 
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ககாடிவைலி வைர்ப்பட்வை               வசராங்க்ககாட்வை 
 
             
                         கர்கைகசிங்கி                      காடி 
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இரசச்சனீ ீசூரணம்
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MATERIALS AND METHODS 
 
PROTOCOL 
 
Study Design 
 An open pilot study on Venpulli was carried out in the post graduate department 
of maruthuvam in Govt.Siddha Medical College attached to Arignar Anna Hospital of 
Indian Medicine, Chennai – 106 during the period of 2014 – 2016. 
 The study was approved by Instititional Ethics Committee (IEC) and the 
approval number is GSMC-CH-ME-2/001/2014. It was registered in Clinical Trials 
Registry – India (CTRI) and the register number is CTRI/REF/2016/06/011520. 
 
Sample size 
 The study is conducted in 20 selected venpulli patients of both genders between 
age groups of 18 to 60 years. 
 
Selection Criteria 
 The patients having following parameters are selected for the study. 
         
 Age: Between 15 to 60 years  
 Sex: Both male and female. 
 Hypo pigmented patches with hyper pigmented border without any structural     
             changes in any part of the body 
 Willing to co operate for taking photographs whenever required with his consent 
 
Exclusion Criteria 
 Albinism  
 thyroid disorder 
 Leprosy 
 STD 
 HIV 
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 Burns 
 Pregnancy and lactation. 
 Fungal infestation  
 Patient with lesion in the lips ,sole , palm and genitalia 
Proforma  
 The case sheet proforma for venpulli was prepared based on Siddha diagnostic 
methodology with necessary modern techniques. 
History taking 
 For better treatments and results a detailed clinical history was taken regarding  
present illness, past illness, family history, menstrual history, occupational history, socio 
economic status, residential area, etc., 
Investigation 
 All patients were screened by the following investigations. This was carried out 
regularly before and after treatment. 
 
 Blood for biochemical examination 
The blood was tested for sugar, urea, serum creatinine to know the renal 
function and its excretion. 
 Urine Examination 
         Albumin, Sugar, Deposits. 
 Thyroid profile 
 Liver function test  
 Renal function test. 
 
Drug and dose schedule: 
  Internal Medicine-Rasacheenee Chooranam – 10mg, bd after food palm jaggery  
                                             for 48 days.  
             External Medicine – Karkadagasingi pattru 
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RESULTS AND OBSERVATION 
 20 cases having venpulli were selected and treated in OPD of PG maruthuvam 
department attached to AAGHIM, Chennai – 106 during the year 2014 – 2016. The result 
and observation during that clinical study are as follows. 
 Gender distribution 
 Age distribution 
 Occupation 
 Socio- economic status 
 Etiology Reference 
 Dietary habits 
  Seasonal occurence 
 Distribution of  Thinai 
 Site of lesion 
 Duration of disease 
 Distribution of mukkutram – vatham 
 Distribution of mukkutram – pitham 
 Distribution of mukkutram – kabham 
 Ezhu udalthathukkal 
 En vagaithervugal 
 Naadi 
 Neikuri 
 Clinical features 
 Clinical improvement in VASI score. 
 Grading of Result. 
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GENDER DISTRIBUTION 
S.No GENDER NUMBER OF CASES PERCENTAGE (%) 
1 Male 11 55% 
2 Female 9 45% 
 
 
 
 
INFERENCE: 
About 55% were males and 45% were females 
 
 
 
55%
45%
GENDER DISTRIBUTION
Male
female
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AGE DISTRIBUTION 
S.No AGE IN YEARS NUMBER OF 
CASES 
PERCENTAGE (%) 
1 18 – 20 yrs 1 5% 
2 21 - 30 yrs 5 25% 
3 31 - 40 yrs  8 40% 
4 41 - 50 yrs  6 30% 
 
 
 
 
 INFERENCE 
Majority of  the case that is 40% were in the 3rd decade, 30% were in the 4th decade, 25% 
were in the 2nd decade, 5% were in the 1st decade 
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OCCUPATION 
S.No OCCUPATION NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Office worker 3 15% 
2 House Wife 7 35% 
3 Business 2 10% 
4 Electrician 0 0% 
5 Student 2 10% 
6 Farmer 3 15% 
7 Others 3 15% 
 
 
INFERENCE 
0ut of 20 patients (100%), 35% were house wife,15% were office worker, 15% were 
farmer, 0% were electrician, 10% were business ,10% were student, 15% were in other 
occupation. 
Office worker House Wife Business Electrician Student Farmer Others
15%
35%
10%
0%
10%
15%
15%
OCCOCOOOCCCCCOCCUPATION 
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SOCIO – ECONOMIC STATUS 
S.No SOCIO – ECONOMIC 
STATUS 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Low Income  
( below 25,000 per annum) 
4 20% 
2 Moderate Income  
(25,000 – 50,000 per annum) 
12 60% 
3   High Income  
( Above 50,000 per annum) 
4 20% 
 
 
 
INFERENCE: 
 Among 20 cases 20% comes under low economic status, 60% of them under 
moderate status and 20% of them under high income status. 
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ETIOLOGY REFERENCE 
      ETIOLOGY  NO OF CASES OUT OF       
        20 
     PERCENTAGE 
  Hereditary           2                 10% 
Anaemia           4                  20% 
   unknown          14                  70% 
 
 
 
 
INFERENCE 
 Among 20 patients, 2 patients (10%) had Hereditary Etiology,4 patients (20%) 
were Anaemia and 14 patient had unknown causes (70%). 
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DIETARY HABITS 
S.No DIET NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vegetarian 6 30% 
2 Mixed diet 14 70% 
 
 
 
INFERENCE 
 Among 20 patients, 6 patients (30%) were taking vegetarian food and 14 patients 
(70%) were taking mixed diet. 
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DIETARY HABITS
Vegetarian
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SEASONAL OCCURENCE 
S.No KAALAM (Season) NUMBER OF CASES PERCENTAGE (%) 
1 Kaarkaalam 
( Mid Aug – Mid Oct) 
3 15% 
2 koothirKaalam 
(Mid Oct – Mid Dec) 
4 20% 
3 Munpanikaalam 
(Mid Dec – Mid Feb) 
10 50% 
4 Pinpanikaalam 
(Mid Feb – Mid Apr) 
3 15% 
5 Elavenirkaalam 
(Mid Apr – Mid Jun) 
0   0% 
6 Muthuvenirkaalam 
(Mid Jun – Mid Aug) 
0                    0% 
 
 
INFERENCE 
 According to paruvakaalam highest incident of 10 cases (50%) were noted in 
munpanikaalam and 4 cases (20%) were noted in Koothirkaalam, 3 cases (15%) were 
noted in kaarkaalam, 3 cases (15%) were noted in Pinpanikaalam.  
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DISTRIBUTION OF THINAI 
S.No THINAI NUMBER OF CASES PERCENTAGE (%) 
1 Kurinji 4                  10% 
2 Mullai 0 0% 
3 Marutham 5 12.5% 
4 Neithal 11 77.5% 
5 Paalai 0 0% 
 
 
 
INFERENCE 
 According to thinai the highest distribution 77.5% was noted in neithal, 12.5% in 
marutham, and 10% in kurinji 
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SITE OF LESION 
SITE OF LESIONS NO OF CASES OUT 
OF 20 
PERCENTAGE (%) 
Scalp 1 5% 
Face 1 5% 
Lips 1 5% 
Abdomen 1 5% 
Upper limb 5 25% 
Lower limb 4 20% 
Multiple 7 35% 
 
 
INFERENCE: 
According to the site of lesion,Out of 20 patient ,1 patient(5%)  had scalp region lesion,1 
patient (5%) had face region lesion, 1 patient(5%) had lips region lesion,1 patient (5%) 
had abdomen region lesion,5 patient (25%) had upper limb region lesion ,4 patient (20%) 
had lower limb region lesion,7 patient (35%) had multiple region lesion. 
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DURATION OF DISEASE 
DURATION OF DISEASE NO OF CASES PERCENTAGE 
7 Years 1 5% 
6 Years 3 15% 
5Years 2 10% 
4Years 4 20% 
3Years 2 10% 
2Years 4 20% 
1Year 2 10% 
8Month 2 10% 
  
 
INFERENCE: 
According to the duration of disease ,out of 20 patient , 1patient (5%) had 7 year of 
disease,3 patient (15%) had 6 year of disease ,2(10%) patient had 5 year of disease,4 
patient (20%) had 4 year of disease,2 patient (10%)had 3 year of disease,4 patient (20%) 
had 2 year of disease,2 patient  (10%) had 1 year of disease, 2 patient ( 10%) had 8 month 
of disease.     
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DISTRIBUTION OF MUKKUTRAM – VATHAM 
S.No VATHAM NUMBER OF CASES PERCENTAGE (%) 
1 Pranan 6 30% 
2 Abanan 6 30% 
3 Viyanan 20 100% 
4 Uthanan 0                  0% 
5 Samanan 0                 0% 
6 Nagan 0 0% 
7 Koorman 3 15% 
8 Kirukaran 0 0% 
9 Devathathan 0 0% 
10 Thananjeyan 0 0% 
 
 
 
INFERENCE 
Out of 20 patients pranan was affected in 6 patients (30%),Abanan was affected in 6 
pateints (30%),Viyanan was affected in 20 patients (100%),  and Koorman was affected 
in 3 patients (15%). 
0%
20%
40%
60%
80%
100%
30% 30%
100%
0% 0% 0%
15%
0% 0% 0%
VATHAM
79 
 
DISTRIBUTION OF MUKKUTRAM – PITHAM 
 
 
 
INFERENCE 
 Out of 20 patientsAnalagam was affected in 0 patients (0%), Ranjagam was 
affected in 6patients (30%), Sathagam was affected in 0 patients (0%), Aalosagam was 
affected in 7patients (35%),pirasagam was affected in 20 patients( 100%) 
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S.No   PITHAM NUMBER OF CASES PERCENTAGE (%) 
1 Analagam 0 0% 
2 Ranjagam 6 30% 
3 Saathagam 0 0% 
4 Alosagam 7 35% 
5 Pirasagam 20 100% 
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DISTRIBUTION OF MUKKUTRAM – KABHAM 
 
S.No KABHAM NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Avalambagam 6 30% 
2 Klethagam 0 0% 
3 Pothagam 0 0% 
4 Tharpagam 0 0% 
5 Santhigam 6 30% 
 
 
 
 
INFERENCE 
 
Out of 20 patients, Avalambagam was affected in 6 patients (30%), Santhigam 
was affected in 6 patients (30%). 
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EZHU UDAL THATHUKAL 
 
S.No EZHU UDAL 
THATHUKAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Saaram 20 100% 
2 Senneer 6 30% 
3 Oon 0 0% 
4 Kozhupu 6 30% 
5 Enbu 6 30% 
6 Moolai 0 0% 
7 Sukkilam /Suronitham 0 0% 
 
 
 
INFERENCE 
Out of 20 patients, Saaram was affected in 20 patients (100%), Senneer was affected in 6 
patients (30%),Kozhupu was affected in 6 patient (30%) ,Enbuwas affected in 6 patients 
(30%). 
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EN VAGAI THERVUGAL 
 
S.No EN VAGAI 
THERVUGAL 
NUMBER OF CASES PERCENTAGE (%) 
1 Naa 6 30% 
2 Niram 20 100% 
3 Mozhi 0 0% 
4 Vizhi 0 0% 
5 Sparisam 0 0% 
6 Malam 6 30% 
7 Moothiram 0 0% 
 
 
INFERENCE 
 
In Envagaithervu, Naa was affected in 6 patients (30%), Niram was affected in 20 
patients (100%), Vizhi was affected in 0 patients (0%) and Malam was affected in 6 
patient (30%)  
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NAADI 
 
S.No NAADI NUMBER OF CASES PERCENTAGE (%) 
1 ValiAzhal 9 45% 
2 ValiIyam 2 10% 
3 AzhalVali 6 30% 
4 AzhalIyam 1 5% 
      5 IyaVatham 1 5% 
      6 Iya Azhal 1 5% 
 
 
 
 
INFERENCE 
 
 9 patients (45%) had Valiazhal naadi, 2 patients (10%) had  ValiIyam naadi,  6 
patients (30%) had Azhalvali naadi, 1 Patient (5%) had Azhaliyam naadi,1 Patient (5%) 
had Iyavatham naadi, 1 patient  (5%) had Iya azhal naadi . 
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NEIKURI 
 
S.No THATHU NEIKURI NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vathaneer Spread like snake 5 25% 
2 Pithaneer Spread like ring 11 55% 
3 Kabhaneer Spread like pearl 4 20% 
 
 
INFERENCE 
 
 5 patients (25%) had vathaneer, 11 patients (55%) had Pithaneer, and 4 patients 
(20%) had Kabhaneer. 
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CLINICAL FEATURES 
 
SIGN AND 
SYMPTOMS 
BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF CASES PERCENTAGE 
(%)S Colour of skin 
 
 
20 
20 
 
          100% 
100% 
14 70% 
70% Depigmention of hair 
 
 
 
 
 
         3           5%             2 1  
Itching  0 0% 0 0% 
Erythema 0 0% 0 0% 
  
 
 
 
INFERENCE : 
     According to the clinical features, Out of 20 patients ,20 patient had colour changes in 
skin before treatment , After treatment 14 patient had recovery of skin color changes, 3 
patient had depigmentation of hair before treatment ,After treatment 2 patient had  
recovery of the depigmented hair .  
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HAEMOGLOBIN LEVEL 
 
S.no Op. no Patient’s name Age/Sex Before 
treatment  
After 
treatment 
1 533 Mrs.Hemavathy 49/F 10 gm 11 gm 
2 547 Mr.Naveenkumar 33/M 11.5 gm 12 gm 
3 780 Mrs. Selvi 30/F 9.4gm 10.3 gm 
4 2706 Mr.Pazhanivel 39/M 9.8 gm 10.4 gm 
5 3110 Mr. Selvaraj 39/M 13 gm 13 gm 
6 6245 Mr.Vinoth 25/M 11 gm 12.5 gm 
7 6408 Mr.Srinivasan 49/M 13 gm 13 gm 
8 4028 Mrs. Selvi 31/F 10.2 gm 11.5 gm 
9 627 Mrs. Shanthi 33/F 10.5 gm 12 gm 
10 783 Mr.Gunasekaran 39/M 9gm 12gm 
11 897 Mrs.Prema 45/F 10.4 gm 11.6gm 
12 3029 Mrs.Anjalai 47/F 9gm 10.4gm 
13 3061 Mis. Uma 25/F 9.8gm 12.4 gm 
14  5471 Mr. Mirath 24/M 10.6 gm 11.3 gm 
15 1927 Mis.Seetha 23/F 9.9 gm 10.6 gm 
16 
 
 
6847 Mr.Periyasamy 45/M 10gm 10.8gm 
17 6893 Mr.Manikandan 19/M 11gm 11.2gm 
18 3074 Mrs. Uma 45/ F 9 gm 12 gm 
19 7153  Mr.Appalnaidu 38/ M 12 gm 13 gm 
20  8527 Mr.Ramamurthi 32/M 11 gm 12.3 gm 
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LABORATORY    INVESTIGaTioN 
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           HAEMATOLOgy  REPORT 
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TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, E – Eosinophil, ESR – Erythrocyte Sedimentation Rate,  
Oec – Occasional epithelial cells, Opc – Occasional pus cells, Alb – Albumin, Sug – Sugar, Dep – Deposit 
 
 
S.No 
 
 
OP.No 
 
 
Name 
 
 
Age/Se
x 
                                       Before Treatment   After 
Treatment 
 Urine Analysis 
Before Treatment 
Urine Analysis 
After Treatment 
TC cells/ 
cu.mm 
D
C 
% 
  ESR  TC 
Cells/cu.
mm 
DC %  
 
 
 
 
ES
R 
 
 
 
Alb
umi
n 
 
sugar 
 
Depos
it 
 
Albu
min 
 
sugar 
 
deposi
t 
 P L E ½ hr 1 
hr 
 P L E ½ 
hr 
 1 hr       
1 533 Mrs.Hemavathy  
49/F 
 
10700 
 
63 
 
34 
 
3 
 
11 
 
24 
 
10700 
 
62 
 
33 
 
5 
 
8 
 
14 
 
NIL 
 
 NIL 
 
NIL 
 
NIL 
 
NIL 
 
NIL 
2 547 Mr.Naveenkumar  
33/M 
 
9400 
 
57 
 
38  
 
5 
 
9 
 
15 
 
9500 
 
60 
 
36 
 
4 
 
8 
 
10 
 
NIL 
 
NIL 
 
NIL 
 
NIL 
 
NIL 
 
NIL 
3 780 Mrs. Selvi 30/F 7600 48 46 6 8 14 7800 52 43 5 8 10 NIL + Opc NIL NIL NIL 
4 2706 Mr.Pazhanivel 39/M 9900 53 40 7 15 30 10200 57 37 6 10 18 NIL NIL NIL NIL NIL NIL 
5 3110 Mr. Selvaraj 39/M 7200 54 40 6 10 20 7800 58 37 5 10 18 NIL N IL NIL NIL NIL NIL 
6 6245 Mr.Vinoth 25/M 9700 58 35 7 18 35 10000 62 33 5 15 30 NIL NIL Opc NIL NIL NIL 
7 6408 Mr.Srinivasan 49/M 8600 55 39 6 5 45 8800 57 37 6 15 30 + NIL NIL NIL NIL NIL 
8 4028 Mrs. selvi 31/F 9200 61  35 4 33 60 9300 63 34 3 17 30 NIL NIL NIL NIL NIL NIL 
9 627 Mrs. Shanthi 33/F 9000 54 40 6 30 62 9200 58 37 5 15 30 NIL ++ oec NIL NIL NIL 
10 783 Mr.Gunasekaran 39/M 8000 55 39 6 12 30 8100 57 37 6 10 15 NIL NIL NIL NIL NIL NIL 
11 897 Mrs. Prema 45/F 8000 55 41 4   8 14 8600 58 39 3 8 10 NIL NIL opc NIL NIL NIL 
12 3029 Mrs. Anjalai 47/F 7400 50 46 4 9 15 7800 58 40 2 8 14  + NIL opc NIL NIL NIL 
13 3061 Mis.Uma 25/F 10000 62 34 4 10 20 10100 58 35 7 10 18 NIL NIL NIL NIL NIL NIL 
14 5471 Mr. Mirath 24/M 8200 63 33 4 15 30 8600 67 30 3 10 15 NIL NIL NIL NIL NIL NIL 
15 1927 Mis. Seetha 23/F 7800 56 37 7 33 60 7900 58 40 2 17 30 NIL NIL Oec NIL NIL NIL 
16 6847  Mr.periyasamy 45/M 9700 58 39 3 18 35 9900 62 36 2 15 30 NIL NIL NIL NIL NIL NIL 
17 6893 Mr.Manikandan 19/M 9200 57 36 7 8 14 9600 60 34 6 5 10 + NIL NIL NIL NIL NIL 
18 3074 Mrs. Uma 45/F 10000 62 34 4 10 20 10100 58 35 7 10 18 NIL NIL opc NIL NIL NIL 
19 7153 Mr.Appalnaidu 38/M 7900 64 33 3 10 20 8200 68 30 2 8 10 NIL +++ NIL NIL NIL NIL 
20 8527 Mr.Ramamurthi 32/M 8600 49 46 5 5 45 8800 56 40 4 15 30 NIL NIL NIL NIL NIL NIL 
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LIST OF PATIENTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.no Op. no Patient’s name Age/Sex Occupation Date of 
medicine 
1 533 Mrs.Hemavathy 49/F House wife 05-10-2015 
2 547 Mr.Naveenkumar 33/M Office worker 05-10-2015 
3 780 Mrs. Selvi 30/F House wife 05-10-2015 
4 2706 Mr.Pazhanivel 39/M Business 12-10-2015 
5 3110 Mr. Selvaraj 39/M Business 20-11-2015 
6 6245 Mr.Vinoth 25/M Office worker 01-12-2015 
7 6408 Mr.Srinivasan 49/M Farmer 12-12-2015 
8 4028 Mrs. Selvi 31/F House wife 28-12-2015 
9 627 Mrs. Shanthi 33/F  House wife 04-01-2016 
10 783 Mr.Gunasekaran 39/M Farmer 04-01-2016 
11 897 Mrs.Prema 45/F House wife 04-01-2016 
12 3029 Mrs.Anjalai 47/F House wife 11-01-2016 
13 3061 Mis. Uma 25/F Student 11-01-2016 
14  5471 Mr. Mirath 24/M  Office 
worker 
21-01-2016 
15 1927 Mis.Seetha 23/F Shop 08-02-2016 
16 6847 Mr.Periyasamy 45/ M Farmer 22-02-2016 
17 6893 Mr.Manikandan 19/M Student 22-02-2016 
18 3074 Mrs. Uma 45/ F  House wife 11-02-2016 
19 7153  Mr.Appalnaidu 38/ M Shop 24-03-2016 
20  8527 Mr.Ramamurthi 32/M Auto Driver 29-03-2016 
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VASI SCORE 
 
S. 
NO 
OP. 
NO 
      HEAD UPPER LIMB       TRUNK LOWER LIMB TOTAL 
SCORE 
    DH AH     DH AH      DT AT DL AL  
B 
T 
 
A 
T 
B 
T 
A
T 
B 
T 
A 
T 
B 
T 
A 
T 
B 
T 
A 
T 
B 
T 
A 
T 
B 
T 
A 
T 
B 
T 
A 
T 
B 
T 
A
T 
1 5471 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.01 
2 3061 2 1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.1 
3 1927 2 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 
4 897 3 1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0.1 
5 533 0 0 0 0 3 1 5 3 0 0 0 0 0 0 0 0 3 0.6 
6 780 0 0 0 0 2 1 4 2 0 0 0 0 0 0 0 0 1.6 0.4 
7 8527 0 0 0 0 2 1 2 1 0 0 0 0 0 0 0 0 0.8 0.2 
8 7153 0 0 0 0 2 1 2 1 0 0 0 0 0 0 0 0 0.8 0.2 
9 3074 0 0 0 0 2 1 2 1 0 0 0 0 0 0 0 0 0.8 0.2 
10 627 0 0 0 0 2 1 2 1 0 0 0 0 0 0 0 0 0.8 0.1 
11 3029 0 0 0 0 3 2 2 1 0 0 0 0 0 0 0 0 1.2 0.4 
12 4028 0 0 0 0 0 0 0 0 2 0 4 0 0 0 0 0 2.4 0 
13 547 0 0 0 0 0 0 0 0 2 1 3 1 0 0 0 0 1.8 0.3 
14 6893 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0.3 0.03 
15 2706 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 1.2 0 
16 3110 0 0 0 0 0 0 0 0 0 0 0 0 3 1 3 2 3.6 0.8 
17 783 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 1 1.6 0.4 
18 6245 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 1 1.6 0.4 
19 6847 0 0 0 0 0 0 0 0 0 0 0 0 3 2 2 1 2.4 0.8 
20 6408 0 0 0 0 0 0 0 0 0 0 0 0 2 1 3 2 2.4 0.8 
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CASE REPORT FOR PATIENTS BASED ON VASI SCORE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S. 
NO 
OP. 
NO 
AGE/ 
SEX 
DOA DOD INITIAL 
VASI  
SCORE 
POST 
VASI 
SCORE 
 
 
RESULT 
1 5471 24/M 21/01/2016 08/03/2016 0.1 0.01 Mild 
2 3061 25/F 11/01/2016 27/02/2016 0.4 0.1 Marked 
3 1927 23/F 08/02/2016 26/03/2016 0.6 0 Marked 
4 897 45/F 04/01/2016 20/02/2016 0.6 0.1 Marked 
5 533 49/F 05/10/2015 21/11/2015 3 0.6 Moderate 
6 780 30/F 05/10/2015 21/11/2015 1.6 0.4 Moderate 
7 8527 32/M 29/03/2016 15/05/2016 0.8 0.2 Moderate 
8 7153 38/M 24/03/2016 09/05/2016 0.8 0.2 Moderate 
9 3074 45/F 11/02/2016 29/03/2016 0.8 0.2 Moderate 
10 627 33/F 04/01/2016 20/02/2016 0.8 0.1 Moderate 
11 3029 47/F 11/01/2016 27/02/2016 1.2 0.4 Moderate 
12 4028 31/M 28/12/2015 07/02/2016 2.4 0  Marked 
13 547 33/M 05/10/2015 21/11/2015 1.8 0.3 Moderate 
14 6893 19/M 21/01/2016 08/03/2016 0.3 0.03 Mild 
15 2706 39/M 12/10/2015 28/11/2015 1.2 0 Marked 
16 3110 39/M 20/11/2015 06/01/2016 3.6 0.8 Moderate 
17 783 39/M 04/01/2016 20/02/2016 1.6 0.4 Moderate 
18 6245 25/M 01/12/2015 17/01/2016 1.6 0.4 Moderate 
19 6847 45/M 22/02/2016 09/04/2016 2.4 0.8 Marked 
20 6408 49/M 12/12/2015  29/01/201 2.4 0.8 Marked 
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FORMULA FOR VASI SCORE: 
           VA SI SCORE= 0.1 × (DH) AH + 0.2 × (DU) AU + 0.3 × (DT) AT + 0.4 × (DL) AL. 
CLINICAL IMPROVEMENT BASED ON VASI SCORE: 
PATIENT TREATED WITH BOTH INTERNEL& EXTERNEL MEDICINE: 
S.NO EFFECT OF TRIAL MEDICINE NO OF PATIENTS PERCENTAGE 
1 Very much worse( ~-50) 2 10% 
2 Much worse(-50 -25) 0 0% 
3 Worse(-26-10) 0 0% 
4 Minimally Worse(-10 0) 0 0% 
5 Minimally Improved(0 10) 0 0% 
6 Improved(10 25) 0 0% 
7 Much Improved(25 50) 11 55% 
8 Very much Improved(+50~) 7 35% 
 
 
 
 
INFERENCE: 
Among 20 patients treated with internal and external medicine in OPD, 2 out of 20 patient 
achieved very much worse condition(10%) in VASI score,11 out of 20 patient achieved much 
improved (55%) in VASI score,7 patient achieved very much improved (35%) in vasi score. 
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CLINICAL IMPROVEMENT BASED ON VASI SCORE 
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GRADING OF RESULTS 
 
S.No GRADING NUMBER OF CASES PERCENTAGE 
(%) 
1 Good 14 70% 
2 Moderate 4 20% 
3 Poor 2 10% 
 
 
 
INFERENCE : 
Out of 20 patients,14 patient shows good result (70%),4 patient shows moderate result (20%),  and 
2 patient shows poor result (10%). 
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GRADING OF RESULT
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OP.NO:6408 
 
BEFORE TREATMENT                                                 DURING TREATMENT 
                                              
                                            AFTER TREATMENT 
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  OP.NO:1927 
   
  BEFORE TREATMENT                           DURING TREATMENT 
                                                            
                                                                         
 
 
 AFTER TREATMENT                           
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OP.NO:547 
 
      BEFORE TREATMENT                                   DURING TREATMENT 
                                                                                                 
                                                                                                                    
                                                   AFTER TREATMENT                                          
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                                                       DISCUSSION 
Venpulli is an acquired idiopathic depigmentory condition and is characterized by                               
completely depigmented macules and patches of varying sizes and shapes. 
 The patients were examined based on Siddha and as well as modern aspects. All the 
necessary investigations were made during the study. The results obtained from their studies were 
discussed below for better conclusion. 
The clinical study of venpulli was carried out in post graduate department of Maruthuvan 
Govt. Siddha medical College, attached to Arignar Anna Hospital of Indian Medicine, 
Arumbakkam, and Chennai – 106 during 2014-2016. 20 Patients of both sexes of various adult age 
groups satisfying the inclusion and exclusion criteria were selected. All necessary investigation 
was done for them and photographs of the lesion were taken. A day before starting the trial 
treatment, cleaning of mukkutram by purgation will be carried out by Agasthiyar Kuzhambu-
100mg, early morning with hot water. All the patients were treated with trial medicine. Hence with 
the help of trial medicines results and observation are noted for this study. 
Trial medicine administered was Rasacheenee  Chooranam (internal) – 10mg bid after food 
    Vehicle: palm jaggery   
    Duration: 48 days (1 Mandalam). 
   Karkadagasingi pattru  for external medicine. 
1. Sex distribution: 
Among 20 cases 11 were males and 9 were females. 
 
2. Age distribution:  
           Majority of the case that is 40% were in the 3rddecade, 30% were in the 4th decade, 
25% were in the 2nd decade, 5% were in the 1stdecade 
3. Occupation : 
Mixed categories of people are affected, from housewife to office worker, students to 
retired person. House wifes and office workers were affected commonly. 
101 
 
4. Food habits: 
Among 20 patients, 6 patients eat vegetarian food and others eat mixed diet. 
5. According to season: 
The highest incidence were noted in Munpani Kaalam (50%) and 20% were noted 
in koothir Kaalam, 15% were noted in kaarkalam and pinpani kaalam 
6. Distribution of thinai: 
According to thinai, the highest distribution 77.5% was noted in neithal, 12.5% in 
Marutham and 10% noted in kurinji. 
7. On clinical manifestations: 
All of my patients had skin colour changes, 15% patient had depigmentation of 
hair. 
8. Mukkutram: 
Distribution of vatham: 
 Among the patients 100% were affected in Viyanan, 30% patient were affected in 
Pranan and Abanan, 15% patient were affected in koorman. 
a. Affected pranan produced dyspnoea. 
b. Affected Abanan produced constipation. 
c. Affected viyanan produce difficulty in movemen & skin colour changes. 
d. Affected Koorman produced impairment of eye sight 
 Distribution of pitham: 
Among the treated patients 100% were affected in Pirasagam, 30% were affected in 
Ranjagam, and 35% were affected in alosagam. 
1. Affected Ranjagam produced pallor of skin, eye and reduced hemoglobin. 
2. Affected pirasagam produced hypopigmentation of skin. 
3. Affected Alosagam produced impairment of eye sight. 
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  Distribution of Kabham: 
Among the patients, 30% were affected in Avalambagam and 30% were affected in 
Santhigam. 
1. Affected Avalambagam produced dyspnoea. 
2. Affected Santhigam produced low back pain, knee joint pain. 
 
9. Ezhu Udal Thathukkal: 
Among the treated patients saram was affected in 100% of patients, senneer in 30% 
,kozhupu and enbu in 30% 
1. Saaram produce tiredness 
2. Senner produce decreased level of haemoglobin. 
3. Kozhupu and enbu produce restricted movements in both knee joints. 
10.  Enn vagai thervugal:  
In this, Naa was affected in 30%, Niram in 100%, Malam in 30%  
1. Naa was affected cases results in paleness of the tongue. 
2. Niram was affected all cases results in the colour of skin changed into white. 
 
11. Naadi: 
On examination of naadi, 45% had vazhi azhal naadi, 10% had vali iyam naadi, 
30% had Azhalvali naadi, 5% had Azhal iyam naadi, 5% had kabha pitha naadi and 5% 
had kabha vatha naadi. 
12. Neikuri: 
On Neikuri examination 25% were having vatha neer, 55% were having pitha neer 
and 20% were having kabha neer. 
A drop of gingely oil dropped into the early morning urine sample in a bowl may 
result in spread like snake called vatham, like a ring in pitham, like pearl in kabham. 
    1.Mode of action of the drug: 
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    According to suvai: 
The trial medicine Rasacheenee chooranam has bitter and astringent taste. 
This taste will equalize the increased pitham which is the main cause for Venpulli. 
This medicine acts against the increased pitham. So it is considered as Ethirurai 
maruthuvam. 
Karkadagasingi pattru  for external 
 According to veeriyam: (nature) 
The trial medicine Rasacheenee chooranam possesses thatpa veeriyam. So it cures 
pitha diseases. 
  By this Rasacheenee chooranam treats Venpulli. 
1.  Bio chemical analysis: 
Rasacheenee chooranam has starch, Iron,zinc ,calcium,reducing sugar and starch. 
2. Toxicological analysis: 
Acute, Sub acute and sub chronic toxicity studies were conducted at Baid Methaw 
college of Pharmacy. At the end of toxicity studies the hematological parameters (TC, DC 
and Hb), Biochemical parameters (LFT, KFT) and histopathology of vital organs like 
Liver, Kidney, Spleen and Lungs were carried out. Rasacheenee Chooranam shows no 
toxic effect. 
3. Statistical analysis: 
The preclinical studies of trial medicine Rasacheenee Chooranam statistically 
analysed and showed significant result. 
     5.Results after treatment: 
               Many of the patients were relieved of their problem, 70% showed good result , 30%        
     Showed  moderate result ,who are relieved of their problem, 10% showed poor result were not           
     relieved of their problem. 
 
104 
 
 
 
 
 
   
SUMMARY 
 
 
 
 
 
                                                      
 
 
 
 
 
105 
 
SUMMARY 
 I like to summarize this study with the following highlights. 
 Females are more prone to get than males according to my studies. 
 In age distribution, 3rd and 4th decades of people are more affected. 
 House wifes and office workers occupy the first two places in occupational 
classification. 
 Most of the patient had mixed diet. 
 Higher incidence of cases were noted in munpani kalam (Mid Dec – Mid Feb) 
 Etiology of venpulli patient had unknown causes in my studies. 
  In the disturbance of vatham,Among  the patients 100% were affected in Viyanan  
            30% patient were affected in Pranan andAbanan,15%patient were affected in  
             koorman. 
 In the disturbance of Ezhu udal thathukkal, 100% were affected by saaram, 30% 
were affected by senneer and 30% were affected by enbu and kozhupu  
 In Naadi, most of the patients having vali azhal naadi(45%).. 
 In Neikuri examination 55% were having pitha neer. 
 Among the patients, 100% had depigmentation of skin colour, 15% had 
depigmentation of hair. 
 All of my patients were administered with my trial medicine Rasacheenee 
chooranam –10mgs bd with Palm jaggery after food for a period of 48 days.-
Internal medicine. 
 External medicine –Karkadagasingi pattru. 
 After treatment with this trial medicine, shows complete cure of venpulli in 35% 
patient, and give moderate result in (55%). 
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CONCLUSION 
 Vitiligo is the most common depigmentary disorder it may occur due to various 
causes and it leads to mental stress and strain. Hence it’s one of the causes of 
psychomatic disorder. 
 Venpulli (vitiligo) is mainly due to derangements of piththa humour. 
 The trial medicine,Rasacheenee chooranam for internal  and karkadagasingi 
pattru for external. 
 The internal medicine of Rasacheenee chooranam had kaippu and thuvarppu 
suvai, neutralize the increased piththam thereby it act as ethururai maruthuvam. 
 The Rasacheenee chooranam reveals no toxicity in the preclinical studies and 
hence proved to be safe for human administration. 
 No contra indication was  reported during the course of the treatment 
 The trial medicine gave good result for skin colour changes in patients. 
 The preparation of trial medicine is economical. 
 The rasacheenee chooranam does not produce any toxicity in preclinically. So it 
is nontoxic and safe drug for venpulli. 
 From this clinical studies, I conclude that the trial medicines which gives a 65-
70% of improvement within minimum of 48 days. Rasacheenee chooranam 
gave complete recovery of venpulli in 35% patient. 
 Therefore the author concluded that the trial medicine RASACHEENEE 
CHOORANAM (INTERNAL) and KARKADAGASINGI PATTRU 
(EXTERNAL) can give better solutions for venpulli (vitiligo). 
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ANNEXURE – II 
   BIO – CHEMICAL          
      ANALYSIS 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
Preparation of Sodium Carbonate extract: 
 
2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 100 ml beaker 
and 20 ml of distilled water is added. The solution is boiled for 10 minutes, cooled and 
then filtered. The filtrate is called sodium carbonate extract. 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared extract is 
taken in a test tube. To this add 2ml of 
4% Ammonium oxalate solution. 
Absence of 
White Precipitate 
Absent 
b 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. Then 2ml 
barium chloride solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with dilute 
nitric acid till the effervescence ceases. 
Then 2ml of silver nitrate solution is 
added. 
 No white precipitate 
obtained 
Absent 
3 Test for Phosphate 
2ml of the extract is treated with  
2 ml of Ammonium molybdate solution 
and 2ml of concentrated nitric acid. 
 
 NoYellow precipitate 
obtained 
Absent 
4 Test for Carbonate: 
2ml of the extract is treated with 2ml of 
magnesium sulphate solution. 
Absence of white 
precipitate 
Absent 
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5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heated with 
copper turnings and concentrated 
sulphuric acid and viewed the test tube 
vertically down. 
Absence of 
reddishbrown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 2ml of 
dilute acetic acid and 2ml of calcium 
chloride solution and heated. 
Absence of white 
precipitate 
Absent 
b 5 drops of clear solution is added with 
2ml of diluted sulphuric acid and 
slightly warmed to this, 1 ml of dilute 
potassium permanganatesolution is 
added. 
 No KMNO4 solution 
Discolourisation 
obtained 
Absent 
8 Test for Nitrite 
3 drops of the extract is placed on a 
filter paper. On that, 2 drops of Acetic 
Acid and 2 drops of Benzidine solution 
is placed. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohol (95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
Absent 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added with 2 ml 
of Potassium iodide solution. 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper Absence of Absent 
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One pinch of substance is made into 
paste with concentrated Hydrochloric 
acid in a watch glass and introduced 
into the non-luminous part of the flame. 
Bluishgreen 
colouredflame. 
b 2ml of the extract is added with excess 
of Ammonia solution 
 
Absence of deep 
blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in drops to 
excess 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate Solution is 
added. 
presence of Blood 
red colour 
Present 
b To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate solution and 2 
ml of concentrated Nitric Acid is 
added. 
Blood red colour 
obtained 
Present 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in drops to 
excess. 
 
presence of 
Whiteprecipitate. 
Present 
15 Test for Calcium 
2 ml of the extract is added with 2 ml 
of 4% Ammonium Oxalate solution. 
Presence of 
Whiteprecipitate. 
Present 
16 Test for Magnesium 
2ml of extract, Sodium Hydroxide 
solution is added in drops to excess. 
Absence of 
Whiteprecipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of Nessler’s 
Absence of 
Reddish brown 
Absent 
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Reagent and excess of Sodium 
Hydroxide solution are added. 
precipitate 
18 Test for Potassium 
A pinch of substance is treated with 2 
ml of Sodium Nitrite solution and then 
treated with 2 ml of Cobal Nitrate in 
30% glacial Acetic acid. 
Absence of Yellow 
precipitate 
 
Absent 
19 Test for Sodium 
2 pinches of the substance is made into 
paste by using Hydrochloric acid and 
introduced into the blue flame. 
 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treated with 2 ml 
of Sodium Hydroxide solution. 
Absence of yellow 
precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 2 ml of 
silver Nitrate solution. 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with weak 
iodine solution 
presence of 
Blue colour 
Present 
23 Test of reducing Sugar 
5ml of Benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 minutes and added 10 drops 
of the extract and again boiled for 2 
minutes. The colour changes are noted. 
Presence of Green 
colour 
Present 
24 Test of the alkaloids 
2ml of the extract is treated with 2ml of 
potassium lodide solution. 
presence of 
Red colour 
Present 
25 Test of the proteins 
2ml of the extract is treated with 2ml of 
5% NaOH, mix well and add 2 drops of 
copper sulphate solution. 
Absence of 
Violet colour 
Absent 
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RESULTS: 
The given sample (Rasacheenee Chooranam) contains  
 Calcium 
 Zinc  
 iron 
 reducing sugar 
  Alkaloids 
 Starch. 
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ANNEXURE – III 
PHYSICO CHEMICAL 
ANALYSIS 
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Sample Name/ID –Rasacheenee chooranam 
Stationary Phase - Silica Gel 60 F254 
Mobile Phase – Toluene : Ethyl Acetate (5 : 1.5 v/v) 
  
 
 
254 nm  
 
 
 366 nm  
 
 575 nm (Derivatized) 
 
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Green 0.49 Light Green 0.09 Light purple 0.13 
Green 0.76 Light Green 0.11 Light purple 0.39 
  Light Blue 0.14 Light purple 0.45 
  Fluorescent Blue  0.44 Light purple 0.82 
  Dark Blue 0.76   
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HPTLC Chromatogram @ 254 nm:  
 
Peak Table @ 254 nm:  
 
 
 
3D Chromatogram @ 254 nm: 
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HPTLC Chromatogram @ 366 nm:  
 
 
Peak Table @ 366 nm:  
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3D Chromatogram @ 366 nm: 
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ANNEXURE – IV 
TOXICOLOGICAL STUDY 
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ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423 
Animal: Healthy wistar albino female rat weighing 200–220 gm 
Studied carried out at three female rat under fasting condition, signs of 
toxicity was observed for every one hour for first 24 hours and every day for about 
14 days from the beginning of the study. 
INTRODUCTION:  
The acute toxic class method is a stepwise procedure with the use of 3 
animals of a single sex per step. Depending on the mortality and/or the moribund 
status of the animals, on average 2-4 steps may be necessary to allow judgment on 
the acute toxicity of the test substance. Morbid animals or animals obviously in pain 
or showing signs of severe and enduring distress shall be humanely killed, and are 
considered in the interpretation of thetest  results  in  the  same  way  as  animals  
that  died  on  test.  The method allows for the determination of an LD50 value only 
when at least two doses result in mortality higher than 0% and lower than 100%. 
 
PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum  number  of  animals  per  step,  sufficient  information  is  obtained  on  
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the  acute toxicity  of  the  test  substance  to  enable  its  classification.  The 
substance is administered orally to a group of experimental animals at one of the 
defined doses.  The substance is tested using a stepwise procedure, each step using 
three animals of a single sex. Absence or presence of compound-related mortality of 
the animals dosed at one step will determine the next step, i.e.; − no further testing is 
needed − dosing of three additional animals with the same dose − dosing of three 
additional animals at the next higher or the next lower dose level. The method will 
enable a judgment with respect to classifying the test substance to one of a series of 
toxicity classes.   
METHODOLOGY   
Selection of animal species:  
The preferred rodent species is rat, although other rodent species may be used.  
Healthy  young  adult  animals  of  commonly  used  laboratory  strain Swiss albino 
is used .  Females should be nulliparous and non-pregnant.  Each animal at the 
commencement of its dosing should be between 8 and 12 weeks old and its weight 
should fall in an interval within±20 % of the mean weight of the animals.   
Housing and feeding conditions:   
  The  temperature  in  the  experimental  animal  room  should  be  22ºC  (+3ºC). 
Although  the  relative  humidity  should  be  at  least  30%  and  preferably  not  
exceed  70% other than during room cleaning the aim should be 50-60%. Lighting 
should be artificial, the sequence being 12 hrs  light, 12 hrs dark. For feeding, 
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conventional laboratory diets may be used with an unlimited supply of drinking 
water. Animals may be grouped and tagged by dose, but the number of animals per 
cage must not interfere with clear observations of each animal.   
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, and 
kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
 
Observation done: 
Group Day 
Body weight Normal 
Assessments of posture Normal 
Signs of Convulsion 
Limb paralysis 
Absence  (-) 
Body tone Normal 
Lacrimation Absence 
Salivation Absence 
Change in skin color No significant colour change 
Piloerection Normal 
Defecation Normal 
 Sensitivity response Normal 
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Locomotion  Normal 
Muscle gripness Normal 
Rearing Mild 
Urination Normal 
 
 
 
1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response  7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia15.Lacrimation 
16. Exophthalmos 17. Diarrhea   18. Writhing   19 Respiration   20.  Mortality 
 
CONCLUSION: 
In the acute toxicity study, the rats were treated with different concentration 
of RASACHEENEE CHOORANAMfrom the range of 5mg/kg to 100mg/kg which 
did not produce signs of toxicity, behavioral changes, and mortality in the test 
groups as compared to the controls when observed during 14 days of the acute 
toxicity experimental period. These results showed that a single oral dose of the 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
100 + - - - - + - - - - - - - - - - - - + - 
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extract showed no mortality of these rats even under higher dosage levels indicating 
the high margin of safety of this extract. In acute toxicity test theRASACHEENEE 
CHOORANAMwas found to be non toxic at the dose level of 100mg/ kg body 
weight.  
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Sub-Acute toxicity test  
The dose selected for the sub acute toxicity study was 10mg, 20mg/kg of  
RASACHEENEE CHOORANAM. All the animals were free of intoxicating 
signs throughout the dosing period of 28 days. No physical changes were 
observed throughout the dosing period. No mortality was observed during 
the whole experiment. No abnormal deviations were observed. No 
significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within 
normal biological and laboratory limits. The weights of organs recorded did 
not show any significant differences in the treatment and the control group 
indicating that RASACHEENEE CHOORANAMwas not toxic to kidney, 
liver and spleen There was no significant changes were observed in 
hemoglobin (Hb), red blood cell (RBC), white blood cell (WBC), packed 
cell volume (PCV), Erythrocyte sedimentation rate (ESR) in all the treated 
groups as compared to respective control groups. Histopathology studies 
were carried out on liver, kidney and spleen and recorded.Blood samples for 
hematological and blood chemical analyses were taken from common 
carotid artery. All rats were sacrificed after the blood collection. The internal 
organs and some tissues were observed for gross lesions. All tissues were 
preserved in 10% neutral buffered formaldehyde solution for 
histopathological examination. 
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SUB ACUTE REPORTS 
RASACHEENEE CHOORANAM( 10 mg/kg) 
HAEMOTOLOGY 
CBC 
WBC    :   6500 cells/cumm 
Differential Count 
NEUTROPHILLS  : 18% 
LYMPHOCYTES  : 76 % 
EOSINOPHILS  : 06 % 
MONOCYTES  : 02 % 
RBC    : 6.5 millions/cumm 
HB    : 14.4 gms%  
PCV    : 39.6 % 
MCV    : 56.5 fL 
MCH    : 16.5 pg  
MCHC   : 29.3 Grams/dl  
PLATELET   : 6.5 Lakhs/cumm 
BIOCHEMISTRY 
Blood sugar   :  98 mg/dl 
BUN    :  36.1 mg/dl 
Creatinine   :  0.4 mg/dl 
SGOT   :  57 U/L 
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SGPT    :  76  U/L 
ALP    :   55 U/L 
T.Protein   :  sgrams/dl 
Albumin   :  4.5  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  131  mg/dl 
Triglycerides  :  59 mg/dl 
HDL    :  32 mg/dl 
LDL    :  67.2 mg/dl 
VLDL   :  23.8 mg/dl 
Ratio 1(T.CHO/HDL)     :  4.44 
Ratio 2(LDL/HDL) :  2.89 
HIISTOPATHOLOGY 
KDNEY                                           LIVER 
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SPLEEN 
 
 
 
RASACHEENEE CHOORANAM( 20 mg/kg) 
HAEMOTOLOGY 
CBC 
WBC    :   5,200 cells/cumm 
Differential Count 
NEUTROPHILLS  : 10% 
LYMPHOCYTES  : 89 % 
EOSINOPHILS  : 01 % 
MONOCYTES  : 00 % 
RBC    : 8.98 millions/cumm 
HB    : 16.9 gms%  
PCV    : 53.6 % 
MCV    : 59.7 Fl 
MCH    : 18.8 pg  
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MCHC   : 31.5 Grams/dl  
PLATELET   : 7.20 Lakhs/cumm 
 
BIOCHEMISTRY 
Blood sugar   :  90  mg/dl 
BUN    :  52.8 mg/dl 
Creatinine   :  0.4 mg/dl 
SGOT   :  67  U/L 
SGPT    :  44  U/L 
ALP    :  45    U/L 
T.Protein   :  4.3  grams/dl 
Albumin   :  2.2  grams/dl 
LIPID PROFILE 
T. Cholesterol  :  112  mg/dl 
Triglycerides  :  69  mg/dl 
HDL    :  26  mg/dl 
LDL    :  72.2  mg/dl 
VLDL   :  13.8  mg/dl 
Ratio 1(T.CHO/HDL)     :  4.30 
Ratio 2(LDL/HDL) :  2.77 
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HISTOPATHHOLOGY 
KIDNEY 
 
LIVER 
 
SPLEEN 
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ANNEXURE - V 
BIO STATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Venpulli (Vitiligo): 
The most popular non parametric statistical tool, namely, McNemar Test analysis 
has been employed to analyses the effectiveness with the help of a hypothesis. 
 
S. 
No 
Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Colour of skin 20(100) 14(70)** 
2. Depigmention of hair 3(15) 2(10)* 
3. Itching  0(0) 0(0) 
4. Erythema 0(0) 0(0)  
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 20 
Inference:  
Since the p value is significant in Colour of skin, Depigmention of hair.So there is 
significant reducing of Colour of skin, Depigmention of hair among the patients for the 
treatment of Venpulli (Vitiligo).Hence it is concluded that the treatment was effectiveand 
significant.   
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VASI SCORE BEFORE AND AFTER TREATMENT 
 
Effect of medicine on VASI Score in human subjects  
S.No. BT 
VASI  
Score 
AT 
VASI  
Score 
1 0.1 0.01 
2 0.4 0.1 
3 0.6 0 
4 0.6 0.1 
5 3 0.6 
6 1.6 0.4 
7 0.8 0.2 
8 0.8 0.2 
9 0.8 0.2 
10 0.8 0.1 
11 1.2 0.4 
12 2.4 0 
13 1.8 0.3 
14 0.3 0.03 
15 1.2 0 
16 3.6 0.8 
17 1.6 0.4 
18 1.6 0.4 
19 2.4 0.8 
20 2.4 0.8 
 
 
Software: spss17 version 
Variables: VASI Score – before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.734 
Before and after treatment mean difference: 1.09 ± 0.78. 
P Value (2 tailed): p<0.001. 
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Inference:  
Since the P value is highly significant (<0.001). So there is significant reducing of 
VASI Score among the patients for the treatment of Venpulli (Vitiligo).Hence it is 
concluded that the treatment was effectiveand significant.  
 
 
HAEMOGLOBIN  LEVEL: 
Effect of Rasacheenee Chooranam on Hb level (gm/dl)in human subjects  
S. no BeforeTreatment(gms/dl) AfterTreatment(gms/dl) 
1. 10  11  
2. 11.5  12  
3. 9.4 10.3  
4. 9.8  10.4  
5. 13  13  
6. 11  12.5  
7. 13  13  
8. 10.2  11.5  
9. 10.5  12  
10. 9 12 
11. 10.4  11.6 
12. 9 10.4 
13. 9.8 12.4  
14. 10.6  11.3  
15. 9.9  10.6  
16. 10 10.8 
17. 11 11.2 
18. 9  12  
19. 12  13  
20. 11  12.3  
 
Software: spss17 version 
Variables: Hb level (gm/dl)– before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
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Confidence Interval: 95% 
Correlation coefficient (r): 0.684 
Before and after treatment mean difference ± SEM: 1.16± 0.86. 
P Value (2 tailed): p<0.001. 
Inference:  
Since the P value is highly significant (<0.001), The hypothesis is not accepted.  So the 
treatment was significantly improving the Hb level among the patients for the treatment 
of Venpulli (Vitiligo).   
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ANNEXURE - VI 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “RASACHEENEE CHOORANAM (INTERNAL) & 
KARKADAGASINGI PATTRU (EXTERNAL)” IN THE TREATMENT OF 
“VENPULLI” (VITILIGO) 
 
 INFORMED CONSENT FORM 
 
“I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have the   
right to withdraw from the study at any time without in any way it affecting my further 
medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
Signature of the Guide:     Signature of the Investigator:   
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வெண்புள்ளி இரசச்சீனி சூரணம் உள்மருந்து  
கற்கடகசிங்கி (வெளிமருந்து) 
 
 
வெண்புள்ளி  இரசச்சீனி சூரணம் உள்மருந்து), கற்கடகசிங்கி (வெளிமருந்து)
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ANNEXURE - VII 
CASE SHEET PROFORMA FOR VENPULLI  
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
 POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2014-2016 
 
OP No / IP No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
 
 
1. Complaints and duration  : 
 
2. History of present illness  : 
 
3. History of past illness  : 
 
4. Personal history   : 
 
5. Occupational history  : 
 
6. Menstrual history   : 
 
7. Personal Habits   : Veg/non veg/smoker/Alcoholic/Tobacco chewer 
 
8. Family History   : 
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GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
 
VITAL SIGNS 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Heart rate    : 
 
SIDDHA ASPECT 
NILAM 
Kurinji                                               : 
Mullai                                               : 
Marutham                                         : 
Neithal                                              : 
Palai                                                  : 
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PARUVA KALAM 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani  : 
Elavenil  : 
Muduenil  : 
 
YAAKKAI (Udal) 
Vatham                       : 
Pitham                        : 
Kabham                      : 
Kalappu                      : 
 
GUNAM 
Saththuvam                : 
Rajotham                    : 
Thamasam                  : 
 
PORI/PULANGAL 
(SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell   : 
Sevi – Hearing   : 
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KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
UYIR THATHUKKAL 
 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
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C.KAPAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
 
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
 
 
MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
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 Elagal    : 
 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
 2.Neikuri 
 
MODERN ASPECT 
 
   Sytemic Examination  
 Inspection   : 
 Palpation   : 
                    Renal angle                     : 
                    Tenderness                      : Present/Absent  
                    Radiation                         :      
 Percussion   : 
 Auscultation   : 
 
     Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system : 
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CLINICAL SIGN AND SYMPTOMS OF VENPULLI 
 
 
S.No 
 
Symptoms 
 
Before 
Treatment 
After Treatment 
10th day 20th day 30th day 40th day 
1 Hypopigmentation 
  Area 
  shape 
     
2 Pruritis      
3 Swelling      
4 Erythema      
5 Depigmentation of hair      
6 Sensation      
7 Scaling      
8 Oozing      
 
 
                                                       INVESTIGATION 
1. BLOOD 
  TC, DC, ESR 
  Bleeding time, Clotting time 
  Blood sugar 
  Blood urea 
 
 
2. URINE 
  Colour 
  Turbidity 
  Albumin 
  Sugar 
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  Deposits 
 Epithelial cells 
 RBC’s 
 Pus cells 
 
3.Thyroid profile 
4.Liver function test  
5.Renal function test. 
 
TRIAL DRUG: 
             RASACHEENEE CHOORANAM  (INTERNAL)  
                                     & 
             KARKADAGASINGI  PATTRU (EXTERNAL) 
 
INTERNAL MEDICINE 
 
Dose: 10 mg  bid  After food 
Adjuvant : palm jaggery 
Duration of Treatment: 48 days 
Pathiam (Do’s and Don’ts) 
 
Prognosis 
 
 
Medical Officer Signature:       HOD 
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